Allergic urticaria

L12_URTICA_ALLERG

allergic urticaria: commonly referred to as hives, is a kind of skin rash notable for pale red, raised, itchy bumps. Hives may cause a burning or stinging sensation. Histamine and other proinflammatory substances are released from mast cells in the skin and tissues in response to the binding of allergen-bound IgE antibodies to high-affinity cell surface receptors. Basophils and other inflammatory cells are also seen to release histamine and other mediators, and are thought to play an important role, especially in chronic urticarial diseases.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L50.0 Hospital discharge: ICD-9 — 7080 Cause of death: ICD-10 — L50.0 Cause of death: ICD-9 — 7080 2 out of 7 registries used, show all original rules.	3624
4. Check minimum number of events None	3624
5. Include endpoints None	3624
6. Filter based on genotype QC (FinnGen only)	3468

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L50
Name in latin: Urticaria allergica

NAME	L12_URTICA_ALLERG
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L500
HD_ICD_9	7080
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L500
COD_ICD_9	7080
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Allergic urticaria based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	34186	19774	14249
Only index persons	28832	17219	11613
Unadjusted period prevalence (%)
Whole population	0.49	0.57	0.40
Only index persons	0.56	0.63	0.44
Median age at first event (years)
Whole population	25.34	32.25	15.58
Only index persons	28.78	34.54	20.24

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3468	2466	1002
Unadjusted period prevalence (%)	0.75	0.87	0.46
Median age at first event (years)	43.14	41.27	47.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3624: Matched controls
36240

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XQ800

NOMESCO Finland

Prick test

5.5

321.0

713

1537

L50.8

ICD-10 Finland

Other urticaria

55.9

307.7

298

C01CA24

ATC

epinephrine; parenteral

9.4

307.7

910

1244

L50.0

ICD-10 Finland

Allergic urticaria

1676.2

307.7

3269

198

L50.9

ICD-10 Finland

Urticaria, unspecified

24.3

307.7

581

283

H02AB06

ATC

prednisolone; systemic

3.8

307.7

2322

11595

T78.4

ICD-10 Finland

Allergy, unspecified

7.9

307.7

572

841

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

+∞

307.7

365

R06AE07

ATC

cetirizine; oral

3.6

292.8

2355

12384

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.9

291.6

756

1851

L50.3

ICD-10 Finland

Dermatographic urticaria

42.5

289.5

174

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

14.8

206.7

187

133

L50.1

ICD-10 Finland

Idiopathic urticaria

31.8

152.4

H02AB07

ATC

prednisone; oral

3.1

137.6

670

2449

R06AX27

ATC

desloratadine; oral

2.4

133.0

1459

7979

J01FF01

ATC

clindamycin; systemic

2.4

125.3

1179

5993

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

5.2

122.0

262

534

R06AE09

ATC

levocetirizine; oral

2.6

104.2

762

3410

T78.3

ICD-10 Finland

Angioneurotic oedema

9.1

101.0

125

142

R03DC03

ATC

montelukast; oral

2.5

100.3

813

3810

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

8.4

93.7

124

153

A92

ICPC

Allergy/allergic reaction NOS

4.2

84.1

235

590

R06AX22

ATC

ebastine; oral

2.3

84.0

789

3913

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

82.6

1538

9858

H02AB04

ATC

methylprednisolone; systemic

2.5

82.5

608

2705

R03AC02

ATC

salbutamol; inhalant

2.0

80.4

2183

15832

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

79.7

491

2002

N05BB01

ATC

hydroxyzine; systemic

3.1

76.7

339

1153

XQ802

NOMESCO Finland

Epicutan test

3.8

76.2

244

675

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

75.3

1525

9968

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

74.8

790

4089

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

5.6

73.8

144

268

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

23.5

70.7

XQ820

NOMESCO Finland

Exposure to medicinal substance

13.6

68.2

D07AA02

ATC

hydrocortisone; topical

2.2

64.3

661

3365

E0000UV, ,

ATC

1.8

63.6

1630

11291

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

60.2

813

4572

L50

ICD-10 Finland

Urticaria

5.0

59.2

128

261

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

58.0

2112

16034

M79.6

ICD-10 Finland

Pain in limb

1.8

57.8

1555

10833

R06AX13

ATC

loratadine; oral

2.1

57.6

678

3621

N02AX02

ATC

tramadol; systemic, rectal

1.8

57.4

1430

9738

A02BC02

ATC

pantoprazole; systemic

1.8

56.4

2319

18156

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

56.2

754

4218

R01AD09

ATC

mometasone; nasal

1.7

56.2

1773

12885

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

55.0

852

5001

L27.2

ICD-10 Finland

Dermatitis due to ingested food

5.7

54.4

102

183

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

5.3

54.2

110

212

R50.9

ICD-10 Finland

Fever, unspecified

2.1

53.5

609

3204

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

52.3

1049

6663

J01FA10

ATC

azithromycin; systemic

1.7

51.3

2259

17795

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

15.9

51.2

D07AB08

ATC

desonide; topical

2.2

50.6

457

2193

J01AA02

ATC

doxycycline; systemic

1.8

50.6

2645

21810

J01DB01

ATC

cefalexin; oral

2.0

50.2

3006

25813

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

50.1

784

4598

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

6.7

49.7

120

L20.0

ICD-10 Finland

Besnier prurigo

2.3

49.4

412

1912

R06.0

ICD-10 Finland

Dyspnoea

1.8

49.3

904

5572

Z3231

NOMESCO Finland

Registered nurse

1.8

49.1

989

6267

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.1

48.9

215

725

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

48.6

713

4089

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

47.4

1087

7140

A02BC05

ATC

esomeprazole; systemic

1.7

47.3

1379

9670

R03BA05

ATC

fluticasone; inhalant

1.9

46.8

738

4329

R51.80

ICD-10 Finland

Headache

1.9

46.8

685

3922

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.4

46.5

339

1482

M54.5

ICD-10 Finland

Low back pain

1.7

45.7

1332

9318

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

45.6

717

4197

J01MA02

ATC

ciprofloxacin; systemic

1.7

45.6

1245

8558

D07AC01

ATC

betamethasone; topical

1.7

44.8

1226

8424

R03BA02

ATC

budesonide; inhalant

1.9

43.9

694

4064

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

42.1

313

1379

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

42.1

979

6419

N03AX16

ATC

[U] pregabalin

1.8

41.4

781

4820

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

40.9

925

6011

J01FA06

ATC

roxithromycin; oral

1.6

40.8

1357

9744

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

40.7

672

3980

J01MA12

ATC

levofloxacin; systemic

1.9

40.6

579

3273

M25.5

ICD-10 Finland

Pain in joint

1.6

39.9

1173

8158

D07AC13

ATC

mometasone; topical

1.7

39.7

997

6656

J01FA09

ATC

clarithromycin; systemic

1.6

39.2

1144

7932

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

37.7

874

5696

XQ801

NOMESCO Finland

Intracutantest

8.4

37.7

N03AX12

ATC

[U] gabapentin; oral

1.9

37.1

555

3180

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

36.8

195

728

R02

ICPC

Shortness of breath/dyspnoea

2.0

36.4

445

2381

N02BE01

ATC

paracetamol; systemic, rectal

1.8

36.2

3095

27565

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

36.2

519

2931

A46

ICD-10 Finland

Erysipelas

2.0

36.0

424

2238

R11

ICD-10 Finland

Nausea and vomiting

2.1

36.0

365

1824

J01MA14

ATC

moxifloxacin; systemic

2.3

35.7

302

1404

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

35.6

425

2254

J01DA01

ATC

[U] cefalexin

1.6

35.5

2136

17388

Z51.6

ICD-10 Finland

Desensitization to allergens

4.2

35.4

231

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

35.1

474

2623

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

35.0

717

4506

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

35.0

1442

10782

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

34.8

1473

11075

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

34.4

488

2743

E000001, ,

ATC

1.7

34.3

752

4813

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

33.9

381

1976

X57

ICD-10 Finland

Unspecified privation

3.8

33.9

104

279

R42

ICD-10 Finland

Dizziness and giddiness

1.7

33.1

723

4616

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

33.0

632

3891

S98

ICPC

Urticaria

6.4

32.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

32.7

488

2787

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

32.4

757

4920

P01AB01

ATC

metronidazole; oral, rectal

1.5

32.1

1389

10442

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

32.1

693

4408

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.8

32.1

262

J45

ICD-10 Finland

Asthma

2.0

31.6

393

2111

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

31.6

306

1501

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

31.5

370

1949

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

31.4

799

5302

J45.8

ICD-10 Finland

Mixed asthma

3.1

31.0

130

426

X58

ICD-10 Finland

Exposure to other specified factors

1.8

30.8

524

3110

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

30.7

320

1613

UJF32

NOMESCO Finland

Coloscopy

1.7

30.7

763

5030

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.2

30.4

124

400

R03AC03

ATC

terbutaline; inhalant

1.8

30.3

506

2988

R01AD58

ATC

fluticasone, combinations; nasal

1.6

30.2

967

6775

S88

ICPC

Dermatitis contact/allergic

3.5

30.0

103

298

R01AD08

ATC

fluticasone; nasal

1.6

30.0

1029

7322

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

29.9

636

4023

E000002, ,

ATC

1.9

29.8

433

2447

M03BX02

ATC

tizanidine; oral

1.5

29.7

2110

17477

A02BA02

ATC

ranitidine; systemic

1.8

29.7

561

3433

N30.0

ICD-10 Finland

Acute cystitis

1.7

29.5

608

3810

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

29.4

248

1150

R01AD12

ATC

fluticasone furoate; nasal

1.5

29.4

1200

8868

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.5

29.3

185

754

R03BB04

ATC

tiotropium bromide; inhalant

2.1

29.3

290

1433

J20

ICD-10 Finland

Acute bronchitis

2.0

29.3

369

1990

L17

ICPC

Foot/toe symptom/complaint

1.6

28.9

951

6696

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

28.7

529

3210

D11AH01

ATC

tacrolimus; topical

4.7

28.7

146

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

28.5

966

6844

J02AC01

ATC

fluconazole; systemic

1.5

28.4

1433

11042

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

28.4

134

470

XQ899

NOMESCO Finland

Other assessment of skin

8.6

28.4

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

6.7

28.0

J46

ICD-10 Finland

Status asthmaticus

3.1

27.9

119

394

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

27.6

944

6693

A02BC01

ATC

omeprazole; systemic

1.6

27.3

849

5889

R52.9

ICD-10 Finland

Pain, unspecified

1.9

26.8

340

1835

H02AB09

ATC

hydrocortisone; systemic

3.1

26.4

112

370

R05

ICPC

Cough

1.6

26.2

848

5925

R96

ICPC

Asthma

1.9

26.0

337

1831

S29

ICPC

Skin symptom/complaint other

1.6

26.0

638

4174

R53

ICD-10 Finland

Malaise and fatigue

1.6

26.0

839

5860

G44.2

ICD-10 Finland

Tension-type headache

1.7

25.9

522

3242

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

25.9

309

1633

L50.2

ICD-10 Finland

Urticaria due to cold and heat

27.2

25.7

L50.5

ICD-10 Finland

Cholinergic urticaria

262.5

25.7

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

25.6

263

1316

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

25.5

1206

9125

R03BA01

ATC

beclometasone; inhalant

1.8

25.4

457

2749

Z2221

NOMESCO Finland

Medical doctor

1.5

25.4

940

6761

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

25.4

836

5861

W84

ICD-10 Finland

Unspecified threat to breathing

9.4

25.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

25.2

784

5423

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

25.0

1073

7952

Z3226

NOMESCO Finland

Physiotherapist

1.6

25.0

599

3891

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

24.8

948

6856

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

24.8

310

1664

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

24.7

418

2468

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

24.6

707

4800

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

24.6

155

632

J01FA01

ATC

erythromycin; systemic

1.7

24.5

544

3463

Z71.8

ICD-10 Finland

Other specified counselling

1.5

24.4

1111

8327

R60.0

ICD-10 Finland

Localized oedema

1.9

24.3

350

1969

AA1AD

NOMESCO Finland

CT of head and brain

1.6

24.1

733

5039

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

24.0

334

1857

N06AX21

ATC

duloxetine; oral

1.8

23.9

414

2461

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

23.9

174

758

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

23.6

344

1940

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

23.5

247

1246

E000003, ,

ATC

2.4

23.5

172

751

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

23.4

774

5416

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

23.4

483

3016

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

23.3

1080

8108

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

23.2

312

1715

R06AX26

ATC

fexofenadine; oral

2.0

23.1

275

1451

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

23.0

187

853

XG410

NOMESCO Finland

Flow-volume spirometry

2.6

23.0

138

549

C03CA01

ATC

furosemide; systemic

1.6

22.9

689

4718

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

22.6

426

2591

344

Kela drug reimbursment

Omalizumab

231.4

22.6

ZXD05

NOMESCO Finland

Urgent procedure

1.5

22.5

994

7380

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

22.5

413

2494

R4110

NOMESCO Finland

Physiotherapy

1.5

22.4

850

6120

L03

ICPC

Low back symptom/complaint

1.5

22.3

947

6973

ZXE00

NOMESCO Finland

One hour or less

1.4

22.3

1283

10015

K30

ICD-10 Finland

Functional dyspepsia

1.8

22.2

383

2273

C07AB07

ATC

bisoprolol; oral

1.4

22.1

1266

9868

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

22.1

365

2138

N02AA05

ATC

oxycodone; systemic

1.7

22.1

447

2774

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

21.9

447

2780

E000006, ,

ATC

2.0

21.9

234

1189

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

21.8

365

2147

H01

ICPC

Ear pain/earache

1.7

21.7

451

2817

N06AX11

ATC

mirtazapine; oral

1.5

21.7

1096

8340

S18

ICPC

Laceration/cut

1.4

21.6

1353

10709

N05CF01

ATC

zopiclone; oral

1.5

21.5

938

6935

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

21.5

160

703

UKC02

NOMESCO Finland

Cystoscopy

1.8

21.4

376

2243

R03BA08

ATC

ciclesonide; inhalant

1.9

21.2

297

1653

A01

ICPC

Pain general/multiple sites

1.8

20.9

305

1721

L04AX03

ATC

methotrexate; systemic

1.8

20.8

320

1833

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

20.8

296

1656

WX002

NOMESCO Finland

Sedation and analgesia

1.6

20.7

561

3744

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

20.6

447

2821

R74

ICPC

Upper respiratory infection acute

1.4

20.6

1253

9842

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

20.6

317

1818

M01AH05

ATC

etoricoxib; oral

1.4

20.2

1988

16913

A02BC03

ATC

lansoprazole; oral

1.5

20.1

816

5938

R03AC12

ATC

salmeterol; inhalant

2.4

20.0

142

611

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

19.9

371

2248

A03

ICPC

Fever

1.5

19.9

662

4623

7089X

ICD-9 Finland

Urticaria, unspecified

+∞

19.8

J30.3

ICD-10 Finland

Other allergic rhinitis

2.3

19.8

157

710

WQ000

NOMESCO Finland

Hyposensibilisation

4.9

19.6

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

19.6

246

1320

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

19.6

2505

22210

L04AA01

ATC

[U] ciclosporin

4.0

19.6

143

D07AD01

ATC

clobetasol; topical

1.6

19.6

501

3294

R03DX05

ATC

omalizumab; parenteral

201.1

19.6

D02AX

ATC

Other emollients and protectives

2.4

19.5

137

587

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

19.5

300

1719

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

19.5

272

1512

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

19.3

1858

15704

J05AB01

ATC

aciclovir; systemic

1.5

19.2

716

5116

L04AD01

ATC

ciclosporin; systemic

3.2

19.2

247

ZY010

NOMESCO Finland

Hospital outpatient

2.0

19.1

214

1105

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

19.0

388

2408

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

19.0

208

1065

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

19.0

1071

8273

S06.0

ICD-10 Finland

Concussion

1.7

18.9

371

2278

M79.1

ICD-10 Finland

Myalgia

1.6

18.5

509

3400

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.8

18.4

323

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

18.3

283

1623

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

18.3

428

2752

J01FA15

ATC

telithromycin; oral

1.7

18.1

319

1901

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

18.1

1412

11498

G47.3

ICD-10 Finland

Sleep apnoea

1.5

18.1

614

4297

E000007, ,

ATC

2.0

18.0

203

1050

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

18.0

261

1468

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

17.9

290

1686

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

17.8

429

2775

J01DA06

ATC

[U] cefuroxime

1.6

17.8

456

2994

B01AB05

ATC

enoxaparin; parenteral

1.4

17.6

879

6627

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

17.6

166

805

J01DC02

ATC

cefuroxime; systemic

2.0

17.5

194

998

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

17.5

222

1197

R21

ICPC

Throat symptom/complaint

1.4

17.4

853

6412

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

17.3

405

2600

M01AE02

ATC

naproxen; oral, rectal

1.4

17.3

1942

16685

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

17.3

277

1606

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

17.1

251

1416

M01AH01

ATC

celecoxib; oral

1.6

17.1

491

3310

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

17.0

296

1758

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

16.9

184

940

R06.4

ICD-10 Finland

Hyperventilation

3.3

16.9

198

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

16.9

119

511

R06AE08, ,

ATC

4.3

16.9

101

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

16.9

968

7473

M54

ICD-10 Finland

Dorsalgia

1.6

16.8

431

2829

R55

ICD-10 Finland

Syncope and collapse

1.7

16.8

298

1779

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

16.8

1012

7876

N05AH04

ATC

quetiapine; oral

1.5

16.7

604

4276

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.5

16.7

170

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

16.7

315

1913

D01

ICPC

Abdominal pain/cramps general

1.6

16.7

434

2859

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

16.7

591

4167

ZX120

NOMESCO Finland

Intravenous

1.8

16.6

278

1633

L53.9

ICD-10 Finland

Erythematous condition, unspecified

4.5

16.6

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

16.5

187

969

R03AC13

ATC

formoterol; inhalant

2.1

16.5

155

750

R06.2

ICD-10 Finland

Wheezing

2.1

16.5

159

777

N05BA04

ATC

oxazepam; oral

1.4

16.5

817

6141

A07AA02

ATC

nystatin; oral

2.1

16.5

166

825

R00.2

ICD-10 Finland

Palpitations

1.8

16.4

274

1607

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

16.4

256

1473

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

16.4

2538

22822

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

16.3

849

6436

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

16.3

193

1016

H57.1

ICD-10 Finland

Ocular pain

2.1

16.1

145

690

L02

ICPC

Back symptom/complaint

1.6

16.1

359

2278

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

16.1

211

1150

R01AD11

ATC

triamcinolone; nasal

1.7

16.0

285

1704

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

15.9

201

1081

N06AB10

ATC

escitalopram; oral

1.4

15.9

737

5467

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

15.9

134

621

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

15.9

206

1119

A01AB09

ATC

miconazole; local oral

1.8

15.9

259

1510

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

15.8

310

1901

L12

ICPC

Hand/finger symptom/complaint

1.5

15.8

534

3727

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

15.7

639

4625

N03AG01

ATC

valproic acid; systemic, rectal

1.9

15.6

199

1074

ZXA05

NOMESCO Finland

Left side

1.5

15.6

653

4752

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

15.6

1585

13339

R07.3

ICD-10 Finland

Other chest pain

1.7

15.6

302

1847

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

15.5

337

2122

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

15.5

315

1952

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

15.4

226

1275

M79.7

ICD-10 Finland

Fibromyalgia

2.2

15.4

133

623

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

15.3

702

5194

D11AX14

ATC

[U] tacrolimus

5.2

15.3

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

15.3

136

645

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

15.3

142

685

A04

ICPC

Weakness/tiredness general

1.5

15.3

500

3464

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

15.2

423

2826

Z2446

NOMESCO Finland

Social worker

1.8

15.2

237

1363

R01AD05

ATC

budesonide; nasal

1.8

15.1

246

1433

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.7

15.0

124

K02.1

ICD-10 Finland

Caries of dentine

1.3

15.0

2064

18101

L16

ICPC

Ankle symptom/complaint

1.6

15.0

393

2592

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

4.4

15.0

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

14.9

258

1529

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

4.1

14.9

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

14.8

128

600

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

14.8

342

2188

M04AA01

ATC

allopurinol; systemic

1.7

14.7

267

1604

M01AB05

ATC

diclofenac; systemic, rectal

1.3

14.7

2069

18178

J01EA01

ATC

trimethoprim; systemic

1.4

14.7

829

6360

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

14.6

377

2477

J05AB11

ATC

valaciclovir; oral

1.5

14.6

444

3028

J01

ICD-10 Finland

Acute sinusitis

1.8

14.6

205

1143

D02AE01

ATC

carbamide; topical

1.8

14.5

205

1144

D11AH02

ATC

pimecrolimus; topical

5.0

14.5

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

14.5

250

1480

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

14.5

401

2677

Z00.0

ICD-10 Finland

General medical examination

1.5

14.5

603

4381

A02BC04

ATC

rabeprazole; oral

1.7

14.4

275

1674

WZC30

NOMESCO Finland

Teaching

1.5

14.4

434

2951

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

14.4

358

2332

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

14.4

195

1075

L04AX01

ATC

azathioprine; systemic

2.1

14.3

138

675

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

14.3

183

989

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.9

14.3

184

997

L26

ICD-10 Finland

Exfoliative dermatitis

27.3

14.3

J01DA09

ATC

[U] cefadroxil

1.4

14.3

832

6412

L28

ICPC

Limited function/disability (L)

1.5

14.2

447

3069

M22.4

ICD-10 Finland

Chondromalacia patellae

2.2

14.2

117

539

SPAT1254

SPAT

Administration of medicine

1.5

14.1

453

3123

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

14.1

1776

15329

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.9

14.0

107

Y96.9

ICD-10 Finland

Unspecified type of accident

2.8

13.9

250

N03AX09

ATC

lamotrigine; oral

1.9

13.9

184

1005

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

13.9

442

3039

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

13.9

1171

9545

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

13.9

410

R05

ICD-10 Finland

Cough

1.4

13.8

656

4875

D09AB01

ATC

zinc bandage without supplements; topical

3.0

13.8

202

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

13.8

143

719

M54.2

ICD-10 Finland

Cervicalgia

1.7

13.7

254

1533

N02BF02

ATC

pregabalin; oral

1.9

13.7

179

975

D11

ICPC

Diarrhoea

1.5

13.7

423

2893

P06

ICPC

Sleep disturbance

1.5

13.6

386

2590

70890

ICD-8 Finland

Urticaria, Acuta

+∞

13.5

7088A

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA CHRONICA NUD]

+∞

13.5

134

Kela drug reimbursment

General erythroderma

+∞

13.5

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

13.5

177

964

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

13.5

328

2123

WX290

NOMESCO Finland

Other blockage of nerve

1.3

13.5

1670

14346

R4190

NOMESCO Finland

Nutritional therapy

2.0

13.5

138

691

SFA20

NOMESCO Finland

Two-surface restoration

1.3

13.5

1972

17321

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

13.5

381

2554

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

13.3

260

1592

P01BA02

ATC

hydroxychloroquine; oral

1.7

13.3

250

1515

XF402

NOMESCO Finland

ECG with work load test

1.7

13.3

250

1515

J01MA06

ATC

norfloxacin; oral

1.5

13.3

380

2555

J04BA02

ATC

dapsone; oral

5.1

13.1

D02

ICPC

Abdominal pain epigastric

1.8

13.1

203

1165

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

13.1

498

3550

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

13.1

218

1279

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

13.0

213

1242

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

3.4

13.0

132

E66.8

ICD-10 Finland

Other obesity

1.8

13.0

190

1072

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

13.0

230

1372

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

13.0

153

806

D11AX15

ATC

[U] pimecrolimus

6.1

12.9

C08CA05

ATC

nifedipine; systemic

1.9

12.9

152

801

ZX112

NOMESCO Finland

Subcutaneous

2.7

12.9

267

ZXD20

NOMESCO Finland

Day surgery

1.5

12.8

384

2605

WX892

NOMESCO Finland

Monitored bed care

1.8

12.8

205

1188

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

12.8

209

1218

N05BA01

ATC

diazepam; systemic, rectal

1.5

12.7

370

2494

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

12.7

386

2628

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

12.6

1021

8250

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

12.6

326

2142

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

12.6

198

1143

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

12.5

644

4848

R09

ICPC

Sinus symptom/complaint

1.6

12.5

303

1960

K08.80

ICD-10 Finland

Toothache NOS

1.6

12.5

300

1936

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

12.4

737

5678

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

12.4

407

2814

SFA10

NOMESCO Finland

One-surface restoration

1.3

12.4

1859

16303

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

12.3

149

791

S21

ICPC

Skin texture symptom/complaint

1.5

12.3

406

2813

ZXA10

NOMESCO Finland

Bilateral

1.4

12.2

507

3673

K29

ICPC

Cardiovascular sympt/complt other

2.2

12.2

100

460

N03AF02

ATC

oxcarbazepine; oral

2.1

12.2

107

506

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

12.2

515

3743

R35

ICD-10 Finland

Polyuria

1.9

12.2

161

881

K07.60

ICD-10 Finland

Snapping jaw

1.8

12.2

190

1094

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

12.1

220

1321

N03AE01

ATC

clonazepam; systemic

1.9

12.1

160

875

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

12.1

159

869

L01BA01

ATC

methotrexate; systemic

2.1

12.0

114

555

B01AB04

ATC

dalteparin; parenteral

1.9

12.0

145

770

R52.2

ICD-10 Finland

Other chronic pain

2.0

12.0

120

597

N06AB04

ATC

citalopram; systemic

1.4

11.9

610

4583

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.4

11.9

120

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.7

11.9

226

JAH01

NOMESCO Finland

Laparoscopy

1.9

11.9

143

759

Z00.8

ICD-10 Finland

Other general examinations

1.7

11.9

246

1531

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

11.8

166

925

R03DC01

ATC

zafirlukast; oral

3.0

11.8

172

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

11.8

220

1333

C09CA06

ATC

candesartan; oral

1.4

11.7

636

4826

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

11.7

156

856

SPAT1263

SPAT

Sampling

1.3

11.7

1333

11262

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

11.7

422

2976

A97

ICPC

No disease

1.4

11.7

557

4136

R52.0

ICD-10 Finland

Acute pain

2.0

11.6

119

597

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

11.6

502

3662

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

11.6

177

1013

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

19.0

11.6

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

11.6

126

646

M89.0

ICD-10 Finland

Algoneurodystrophy

3.5

11.6

108

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

11.5

225

1378

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

3.2

11.5

138

C10AC01

ATC

colestyramine; oral

2.3

11.5

375

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

11.5

273

1758

H03AA01

ATC

levothyroxine sodium; systemic

1.4

11.5

703

5438

70891

ICD-8 Finland

Urticaria, Recidivans, Chronica

+∞

11.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.4

1448

12385

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

3.7

11.4

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

11.4

203

1215

L01

ICPC

Neck symptom/complaint

1.4

11.3

501

3669

D10

ICPC

Vomiting

1.6

11.3

244

1535

A08

ICPC

Swelling

1.9

11.3

132

694

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.9

11.3

147

801

Z01.2

ICD-10 Finland

Dental examination

1.3

11.3

1560

13484

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

11.3

637

4863

N06AX16

ATC

venlafaxine; oral

1.4

11.2

467

3381

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

11.2

215

1311

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

11.2

176

1015

SPAT1260

SPAT

Consultation of another employee

1.4

11.2

514

3787

N03AX11

ATC

topiramate; oral

2.1

11.2

463

TQW80

NOMESCO Finland

Local dermatologic skincare

2.4

11.2

317

S02

ICPC

Pruritus

2.0

11.1

123

634

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

11.1

281

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.1

11.1

146

Z2445

NOMESCO Finland

Psychologist

1.8

11.1

151

834

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.9

11.1

WX320

NOMESCO Finland

Spinalanesthesy

1.4

11.1

649

4982

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.4

11.1

306

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

11.1

294

1943

M23.8

ICD-10 Finland

Other internal derangements of knee

2.0

11.0

120

615

UJD02

NOMESCO Finland

Gastroscopy

2.0

11.0

123

636

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

11.0

101

486

SGA01

NOMESCO Finland

Emergency treatment

1.4

11.0

529

3928

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

11.0

209

1271

M02AA07

ATC

piroxicam; topical

1.3

11.0

945

7674

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

11.0

119

609

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

11.0

257

1648

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

11.0

164

932

R12

ICD-10 Finland

Heartburn

1.6

11.0

243

1538

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

10.9

335

2283

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

10.9

236

R03DA04

ATC

theophylline; systemic, rectal

2.0

10.9

124

646

R31

ICD-10 Finland

Unspecified haematuria

1.7

10.9

217

1337

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

10.9

403

N05CF02

ATC

zolpidem; oral

1.4

10.9

505

3728

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

10.8

200

1208

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

10.8

1194

10019

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

10.8

158

893

C03DA01

ATC

spironolactone; oral

1.6

10.8

269

1752

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.9

10.8

143

784

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

10.6

10.8

A02BA04

ATC

nizatidine; systemic

1.7

10.7

177

1037

J02AC02

ATC

itraconazole; systemic

1.4

10.7

498

3678

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

10.6

168

971

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

10.6

395

2802

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

10.6

269

1760

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

10.6

794

6324

N89

ICPC

Migraine

1.8

10.6

149

833

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

10.5

242

1545

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

10.5

495

3661

A04AA01

ATC

ondansetron; systemic, rectal

1.6

10.5

221

1380

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

10.5

301

2021

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

10.5

127

675

E86

ICD-10 Finland

Volume depletion

2.6

10.5

229

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.0

10.5

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

4.4

10.5

SPAT1283

SPAT

Restricted health certificate

1.3

10.5

692

5406

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

10.5

775

6157

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

10.5

137

748

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

10.4

229

1446

7088B

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA RECURRENS NUD]

+∞

10.4

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.9

10.4

137

750

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

10.4

113

580

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

10.4

302

2036

D06

ICPC

Abdominal pain localized other

1.6

10.4

279

1849

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

10.3

321

2194

XQ810

NOMESCO Finland

Physical test for urticaria

32.6

10.3

R03AA01

ATC

epinephrine; inhalant

32.6

10.3

C07AA05

ATC

propranolol; systemic

1.3

10.3

659

5124

S71

ICPC

Herpes simplex

3.5

10.3

102

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

10.3

183

1095

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

10.3

790

6311

ZXA00

NOMESCO Finland

Right side

1.3

10.2

672

5248

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

10.2

306

2078

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

10.1

138

763

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.7

10.1

193

R06AX18

ATC

acrivastine; oral

2.2

10.1

396

H92.0

ICD-10 Finland

Otalgia

1.6

10.1

210

1309

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.6

10.1

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

10.1

202

1248

S01GX05

ATC

lodoxamide; ophthalmic

2.8

10.0

172

TNG10

NOMESCO Finland

Puncture of knee

3.0

10.0

145

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

10.0

364

2570

A99

ICPC

Disease/condition unspecnature/site

1.6

10.0

261

1719

N01

ICPC

Headache

1.4

9.9

439

3211

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

9.9

361

2547

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

9.9

139

776

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.8

9.9

149

850

N03AF01

ATC

carbamazepine; oral, rectal

1.9

9.9

128

697

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

9.9

105

535

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

9.9

361

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

9.9

536

4060

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.9

9.9

116

612

N07BA03

ATC

varenicline; oral

1.8

9.8

141

793

R01AD01

ATC

beclometasone; nasal

1.4

9.8

449

3304

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

2.0

9.8

106

543

XKD00

NOMESCO Finland

Uroflowmetry

1.5

9.8

267

1775

XQ830

NOMESCO Finland

Exposure to foodstuff

8.7

9.8

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

9.8

362

2564

A06AD11

ATC

lactulose; oral

1.5

9.7

342

2396

D06AX01

ATC

fusidic acid; topical

1.5

9.7

289

1958

Z50.1

ICD-10 Finland

Other physical therapy

1.8

9.6

140

790

A28

ICPC

Limited function/disability NOS

1.5

9.6

364

2587

M10.9

ICD-10 Finland

Gout, unspecified

1.8

9.6

130

718

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

9.6

333

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

9.6

870

7098

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

9.6

278

1873

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

9.5

500

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

9.5

211

1336

L04

ICPC

Chest symptom/complaint

1.7

9.5

182

1110

N02AC04

ATC

dextropropoxyphene; oral

2.2

9.5

373

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

9.5

532

4047

U02

ICPC

Urinary frequency/urgency

1.4

9.5

420

3071

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

9.5

143

816

D07XC01

ATC

betamethasone; topical

1.5

9.5

304

2092

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

9.4

273

1838

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.2

9.4

329

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

9.4

581

4486

C10AA07

ATC

rosuvastatin; oral

1.3

9.4

758

6083

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

9.4

337

2370

S04

ICPC

Lump/swelling localized

1.5

9.4

323

2253

K59.0

ICD-10 Finland

Constipation

1.8

9.4

151

878

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

9.4

171

1031

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

9.3

325

2274

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

9.3

170

1025

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

9.3

170

1025

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

9.3

223

1440

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

9.2

123

676

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

3.1

9.2

125

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

9.2

728

5829

H29

ICPC

Ear symptom/complaint other

1.5

9.2

306

2122

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.1

9.2

392

A03FA02

ATC

cisapride; oral, rectal

1.6

9.1

188

1169

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.0

9.1

131

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.9

9.1

106

557

T82

ICPC

Obesity

1.8

9.1

132

745

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

9.1

204

1296

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

9.1

400

C08CA01

ATC

amlodipine; oral

1.3

9.1

854

6992

H60.8

ICD-10 Finland

Other otitis externa

2.0

9.1

461

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

9.1

153

903

K04.0

ICD-10 Finland

Pulpitis

1.5

9.0

307

2137

XF404

NOMESCO Finland

Ambulatory ECG

1.6

9.0

210

1346

W19

ICD-10 Finland

Unspecified fall

1.5

9.0

265

1790

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

9.0

331

2340

J04.0

ICD-10 Finland

Acute laryngitis

1.7

9.0

145

845

JN4AD

NOMESCO Finland

Body CT examination

1.6

9.0

217

1404

A10BJ02

ATC

liraglutide; parenteral

2.1

9.0

389

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

9.0

142

823

N06AA09

ATC

amitriptyline; systemic

1.5

8.9

239

1582

N06AA10

ATC

nortriptyline; systemic

2.3

8.9

286

N06AX12

ATC

bupropion; oral

1.5

8.9

247

1648

H01.0

ICD-10 Finland

Blepharitis

1.6

8.9

207

1327

B02.9

ICD-10 Finland

Zoster without complication

1.7

8.9

165

999

K29.1

ICD-10 Finland

Other acute gastritis

2.9

8.9

144

R51

ICD-10 Finland

Headache

1.6

8.9

187

1170

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

8.9

164

992

L08

ICPC

Shoulder symptom/complaint

1.3

8.9

587

4579

R83

ICPC

Respiratory infection other

1.3

8.9

929

7708

S01GX08

ATC

ketotifen; ophthalmic

1.7

8.9

152

901

SPAT1312

SPAT

General health counselling

1.3

8.9

1024

8598

R4120

NOMESCO Finland

Occupational therapy

1.6

8.8

186

1164

M48.0

ICD-10 Finland

Spinal stenosis

1.5

8.8

260

1758

R01AC01

ATC

cromoglicic acid; nasal

1.8

8.8

135

775

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

8.8

176

1087

S80.0

ICD-10 Finland

Contusion of knee

1.6

8.8

232

1531

Y94.0

ICD-10 Finland

Accident at home

2.4

8.8

232

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.0

8.8

426

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

8.8

129

732

L20.8

ICD-10 Finland

Other atopic dermatitis

2.7

8.8

162

A01AB04

ATC

amphotericin B; local oral

1.9

8.7

112

610

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

8.7

144

846

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

8.6

415

T90

ICPC

Diabetes non-insulin dependent

1.4

8.6

518

3981

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.3

8.6

259

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

8.6

247

1661

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

8.6

211

1370

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

2.7

8.6

158

KMAK, ,

NOMESCO Finland

1.2

8.6

1670

14843

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

8.6

272

M54.1

ICD-10 Finland

Radiculopathy

1.9

8.6

108

584

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

8.6

343

2464

F41.00

ICD-10 Finland

Moderate panic disorder

2.3

8.6

285

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.0

8.5

410

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

8.5

684

5481

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.7

8.5

137

798

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

8.5

224

1478

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3.8

8.5

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.4

8.5

242

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.0

8.5

126

S01GX02

ATC

levocabastine; ophthalmic

1.6

8.5

187

1184

R13

ICD-10 Finland

Dysphagia

1.6

8.5

172

1067

L86

ICPC

Back syndrome with radiating pain

1.7

8.4

163

998

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.0

8.4

474

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

8.4

249

1685

P03

ICPC

Feeling depressed

1.4

8.4

365

2660

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

8.4

1158

9910

M01AH02

ATC

rofecoxib; oral

1.5

8.4

293

2052

W99

ICD-10 Finland

Exposure to other and unspecified man-made environmental factors

4.9

8.4

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

7.9

8.3

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

8.3

131

758

M54.8

ICD-10 Finland

Other dorsalgia

1.7

8.3

137

803

L20

ICPC

Joint symptom/complaint NOS

1.9

8.3

106

575

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

8.3

220

1453

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.9

8.3

133

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.7

8.3

154

933

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

8.3

137

804

U05

ICPC

Urination problems other

1.8

8.3

115

641

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.5

8.3

214

B01AA03

ATC

warfarin; systemic

1.4

8.3

356

2590

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

8.3

145

866

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

8.2

145

867

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

8.2

212

1393

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

8.2

256

1752

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.1

8.2

349

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

8.2

410

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.4

8.2

240

ACC51

NOMESCO Finland

Release of median nerve

1.6

8.2

202

1315

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

8.1

226

1509

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

8.1

166

1031

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

8.1

223

1486

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.5

8.1

D72.1

ICD-10 Finland

Eosinophilia

4.5

8.1

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.2

8.1

279

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

8.1

144

863

C09CA01

ATC

losartan; oral

1.3

8.1

577

4546

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.8

8.1

107

588

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

8.1

124

713

R2110

NOMESCO Finland

Giving the first information

1.6

8.1

203

1326

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

8.1

198

1286

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

8.1

175

1104

R68.2

ICD-10 Finland

Dry mouth, unspecified

3.8

8.1

C09AA05

ATC

ramipril; oral

1.3

8.0

513

3978

N03AX14

ATC

levetiracetam; systemic

2.0

8.0

386

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

8.0

1315

11458

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.5

8.0

182

L13

ICPC

Hip symptom/complaint

1.4

8.0

451

3434

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.0

8.0

442

F01

ICPC

Eye pain

1.9

8.0

491

I50.0

ICD-10 Finland

Congestive heart failure

1.7

7.9

127

739

R03BB01

ATC

ipratropium bromide; inhalant

2.0

7.9

408

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.2

7.9

288

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.2

7.9

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.0

7.9

415

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

7.9

485

SPAT1310

SPAT

Counselling related to known health issue

1.3

7.9

955

8042

R25.2

ICD-10 Finland

Cramp and spasm

2.1

7.9

322

SFA30

NOMESCO Finland

Three-surface restoration

1.2

7.8

1215

10513

A11

ICPC

Chest pain NOS

1.6

7.8

202

1327

L29

ICPC

Musculoskeletal sympt/complt other

1.5

7.8

238

1620

L04AB04

ATC

adalimumab; parenteral

2.1

7.8

349

S92.5

ICD-10 Finland

Fracture of other toe

1.9

7.8

480

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

7.8

219

1466

J01CA04

ATC

amoxicillin; systemic

1.3

7.8

2847

26912

N80.0

ICD-10 Finland

Endometriosis of uterus

2.1

7.8

343

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.8

7.8

117

669

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

7.8

310

SPAT1097

SPAT

Recording of ECG

1.4

7.8

334

2430

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

7.8

144

L09

ICPC

Arm symptom/complaint

1.7

7.7

146

889

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

7.7

291

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

7.7

398

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

7.7

2344

21698

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

7.7

214

1429

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.2

7.7

285

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

7.7

160

999

R03BB07

ATC

umeclidinium bromide; inhalant

3.5

7.7

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

7.7

165

1039

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.2

7.7

273

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

7.6

157

978

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

7.6

137

824

N02BF01

ATC

gabapentin; oral

1.5

7.6

218

1466

M02AA10

ATC

ketoprofen; topical

1.4

7.6

400

3010

S01GX09

ATC

olopatadine; ophthalmic

1.9

7.6

485

A77

ICPC

Viral disease other/NOS

1.7

7.6

120

697

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.6

1248

10861

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

7.6

150

926

M54.3

ICD-10 Finland

Sciatica

1.6

7.5

157

981

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

7.5

262

JN4BD

NOMESCO Finland

Extensive body CT

1.5

7.5

226

1535

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.9

7.5

465

K07

ICPC

Swollen ankles/oedema

1.8

7.5

100

551

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.0

7.5

396

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

7.5

480

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.5

339

2489

N06AX22

ATC

agomelatine; oral

2.0

7.4

404

P25

ICPC

Phase of life problem adult

1.6

7.4

150

930

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

7.4

108

612

3DX05, ,

NOMESCO Finland

80.3

7.4

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

7.4

496

R75

ICPC

Sinusitis acute/chronic

1.6

7.4

157

986

WVA20

NOMESCO Finland

Medicine administration

2.0

7.4

357

M77.4

ICD-10 Finland

Metatarsalgia

1.6

7.4

176

1137

G43.8

ICD-10 Finland

Other migraine

2.2

7.3

291

L15

ICPC

Knee symptom/complaint

1.3

7.3

661

5368

J06.0

ICD-10 Finland

Acute laryngopharyngitis

2.7

7.3

137

395

Kela drug reimbursment

Dupilumab

8.4

7.3

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

3.0

7.3

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

7.3

393

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

7.3

421

S97

ICPC

Chronic ulcer skin

1.7

7.3

125

743

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

7.3

312

NGE10

NOMESCO Finland

Incision or suture of capsule of knee joint

3.1

7.3

M01AB55

ATC

diclofenac, combinations; oral

1.6

7.3

150

936

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

7.3

424

3243

D05BB02

ATC

acitretin; oral

2.3

7.3

228

K04.08

ICD-10 Finland

Other specified pulpit

1.5

7.3

246

1713

SPAT1211

SPAT

Application of soft bandage

1.5

7.3

242

1680

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

7.2

354

2632

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

7.2

169

1086

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

7.2

114

662

SPAT1139

SPAT

Nutrition survey

1.9

7.2

458

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.2

7.2

261

B02AA02

ATC

tranexamic acid; systemic

1.3

7.2

443

3416

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.7

7.2

123

731

Z01.7

ICD-10 Finland

Laboratory examination

1.3

7.2

418

3196

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.2

1118

9662

L04AA24

ATC

abatacept; parenteral

3.9

7.2

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

7.1

301

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

7.1

152

956

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

7.1

510

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

7.1

103

583

S01

ICPC

Pain/tenderness of skin

1.7

7.1

127

763

R06AX12

ATC

terfenadine; oral

1.7

7.1

133

809

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

7.1

126

756

S76

ICPC

Skin infection other

1.7

7.1

135

825

D11AH05

ATC

dupilumab; topical

7.9

7.1

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

7.1

154

973

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.2

7.1

269

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.8

7.1

107

614

M81.4

ICD-10 Finland

Drug-induced osteoporosis

6.0

7.1

XA402

NOMESCO Finland

ENMG

2.1

7.0

316

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.9

7.0

112

L30.3

ICD-10 Finland

Infective dermatitis

1.8

7.0

512

U07

ICPC

Urine symptom/complaint other

1.5

7.0

184

1214

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.8

7.0

107

615

L04AA13

ATC

[U] leflunomide

2.0

7.0

330

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

7.0

178

1167

T93.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of lower limb

3.1

7.0

N29

ICPC

Neurological sympt/complt other

2.3

7.0

232

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.2

7.0

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

7.0

144

899

D07AC14

ATC

methylprednisolone aceponate; topical

1.7

7.0

129

783

S06

ICPC

Rash localized

1.6

7.0

151

954

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

6.9

273

1955

GD1AA, ,

SPAT

1.4

6.9

365

2746

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

2.2

6.9

265

R03CC02

ATC

salbutamol; systemic

1.5

6.9

245

1721

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

6.9

488

3836

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.6

6.9

141

878

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.1

6.9

292

N06AB06

ATC

sertraline; oral

1.4

6.9

356

2671

U01

ICPC

Dysuria/painful urination

1.5

6.9

244

1714

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

6.9

229

1589

K11.88

ICD-10 Finland

Other diseases of salivary glands

7.5

6.9

L18

ICPC

Muscle pain

1.7

6.9

117

694

L50.60

ICD-10 Finland

Allergic contact urticaria

13.8

6.9

R33

ICD-10 Finland

Retention of urine

1.6

6.9

139

863

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.2

6.9

253

R81

ICPC

Pneumonia

1.9

6.9

480

R51.81

ICD-10 Finland

Facial pain NOS

2.0

6.9

374

G04CA02

ATC

tamsulosin; oral

1.4

6.9

345

2577

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

6.9

150

950

R49.01

ICD-10 Finland

Functional dysphonia

1.9

6.8

459

J01DA08

ATC

[U] cefaclor

1.3

6.8

408

3130

WX402

NOMESCO Finland

General anaesthesia

1.3

6.8

606

4908

C08CA13

ATC

lercanidipine; oral

1.4

6.8

302

2208

A10AE04

ATC

insulin glargine; parenteral

1.5

6.8

222

1534

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

6.8

327

N02AJ13

ATC

tramadol and paracetamol; systemic

2.1

6.8

307

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

6.8

231

1610

C07AB02

ATC

metoprolol; systemic

1.3

6.8

423

3266

L51.9

ICD-10 Finland

Erythema multiforme, unspecified

10.9

6.8

S87

ICPC

Dermatitis/atopic eczema

1.9

6.8

439

R04.2

ICD-10 Finland

Haemoptysis

2.0

6.8

355

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

6.8

432

F29

ICPC

Eye symptom/complaint other

1.4

6.8

269

1930

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.8

576

4640

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.8

6.8

519

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

6.7

447

XQ832

NOMESCO Finland

Other provocation test

16.7

6.7

SPAT1301

SPAT

No procedures

1.2

6.7

879

7448

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

6.7

364

2752

R05DA01

ATC

ethylmorphine; oral

1.5

6.7

197

1333

R06.5

ICD-10 Finland

Mouth breathing

1.5

6.7

231

1614

A27

ICPC

Fear of other disease NOS

1.7

6.7

127

776

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.8

6.7

477

D69.0

ICD-10 Finland

Allergic purpura

3.2

6.7

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

6.7

117

700

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

6.7

252

1792

EB1VA, ,

NOMESCO Finland

1.4

6.7

349

2624

N17

ICPC

Vertigo/dizziness

1.4

6.7

316

2338

T78.9

ICD-10 Finland

Adverse effect, unspecified

22.5

6.7

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.1

6.7

263

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

6.6

108

633

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

6.6

101

581

L20

ICD-10 Finland

Atopic dermatitis

1.7

6.6

107

626

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

6.6

559

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

2.2

6.6

257

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

6.6

175

1159

L52

ICD-10 Finland

Erythema nodosum

5.5

6.6

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

6.6

643

5268

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

6.6

231

1620

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.0

6.6

352

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

2.5

6.6

163

M01AX17

ATC

nimesulide; oral

1.3

6.6

557

4484

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.7

6.6

104

605

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

6.6

332

2483

H10

ICD-10 Finland

Conjunctivitis

1.4

6.6

237

1672

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.8

6.6

561

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

6.5

212

1464

ZX108

NOMESCO Finland

Inhalation

3.3

6.5

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.9

6.5

374

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.2

6.5

239

R30.0

ICD-10 Finland

Dysuria

1.7

6.5

122

743

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.9

6.5

424

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.1

6.5

259

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.7

6.5

111

660

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

6.5

232

1634

SDA03

NOMESCO Finland

Periodontal treatment

1.2

6.5

1240

10912

N05

ICPC

Tingling fingers/feet/toes

2.7

6.5

129

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

6.5

181

1213

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

6.2

6.5

1220

FHL

Arthroscopy

1.8

6.5

512

R15

ICD-10 Finland

Faecal incontinence

1.9

6.4

376

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

6.4

247

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.7

6.4

114

685

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

6.4

180

1208

XCK00

NOMESCO Finland

Perimetry

1.6

6.4

137

864

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

6.4

137

864

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

1.8

6.4

521

B03XA02

ATC

darbepoetin alfa; parenteral

2.2

6.4

222

S20.2

ICD-10 Finland

Contusion of thorax

1.6

6.4

130

810

N05CD07

ATC

temazepam; oral

1.4

6.4

238

1690

N06AB03

ATC

fluoxetine; oral

1.4

6.4

351

2662

M22.0

ICD-10 Finland

Recurrent dislocation of patella

2.3

6.3

197

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

1.9

6.3

378

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.2

6.3

229

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

6.3

126

780

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.7

6.3

119

G43

ICD-10 Finland

Migraine

1.5

6.3

189

1285

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.1

6.3

B07.9

ICD-10 Finland

Verruca simplex

1.7

6.3

108

643

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

6.3

114

689

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

6.3

218

1526

D09

ICPC

Nausea

1.5

6.3

164

1083

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

3.3

6.3

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

6.3

364

2782

WW500

NOMESCO Finland

Blood transfusion

1.7

6.3

569

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.8

6.3

103

69598

ICD-8 Finland

Erythematous condition, Alii definiti

+∞

6.2

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.8

6.2

466

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.1

6.2

270

M01AX01

ATC

nabumetone; oral

1.8

6.2

547

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

6.2

230

1629

L30.0

ICD-10 Finland

Nummular dermatitis

1.8

6.2

525

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

6.2

637

5246

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

6.2

115

699

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.9

6.2

D05AX52

ATC

calcipotriol, combinations; topical

1.6

6.2

125

777

N05BA12

ATC

alprazolam; oral

1.4

6.2

265

1928

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.5

6.2

156

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

6.2

285

2100

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

6.2

101

594

A60

ICPC

General and Unspecified, Result test/procedure

1.7

6.2

117

716

U72

ICPC

Urethritis

1.9

6.2

375

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

6.1

299

2223

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.7

6.1

103

610

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

6.1

910

7805

A29

ICPC

General symptom/complaint other

1.4

6.1

320

2407

K03.00

ICD-10 Finland

Approximal wear

1.5

6.1

200

1385

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

6.1

138

882

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

6.1

709

5923

R60.1

ICD-10 Finland

Generalized oedema

3.0

6.1

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.2

6.1

207

XG460

NOMESCO Finland

Short time oxymetry

2.5

6.1

151

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

6.1

115

703

B35.3

ICD-10 Finland

Tinea pedis

1.6

6.1

119

734

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.1

6.1

273

L11

ICPC

Wrist symptom/complaint

1.4

6.1

278

2046

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

6.1

132

836

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

6.1

384

D29

ICPC

Digestive symptom/complaint other

1.9

6.1

356

K04

ICPC

Palpitations/awareness of heart

1.6

6.0

142

916

G04BD12

ATC

mirabegron; oral

1.4

6.0

241

1732

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

6.0

464

A10BK03

ATC

empagliflozin; oral

1.5

6.0

205

1430

C10AA05

ATC

atorvastatin; oral

1.2

6.0

890

7625

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

3.6

6.0

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

6.0

392

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.7

6.0

109

659

K76.9

ICD-10 Finland

Liver disease, unspecified

2.4

6.0

158

A07AA09

ATC

vancomycin; oral

2.5

6.0

146

R03AK11

ATC

formoterol and fluticasone; inhalant

1.9

6.0

364

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

6.0

257

1870

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.3

6.0

183

A06AC51

ATC

ispaghula, combinations; oral

1.6

6.0

118

729

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019420) Tryptase [Mass/volume] in Serum or Plasma

136

123

11.45

129.47

1.4

1.5

5.16

7.11

ug/l

0.99

128

105

(3005322) IgE [Units/volume] in Serum or Plasma

570

2041

3.13

120.26

1.6

1.3

386.97

204.30

u/ml

2.14

539

1880

(3013115) Eosinophils [#/volume] in Blood

2145

15125

2.02

90.00

8.0

6.2

0.21

0.19

e9/l

3.44

1916

13333

(3006504) Eosinophils/100 leukocytes in Blood

1994

13717

2.01

89.59

7.9

6.0

2.93

2.82

1.36

1866

12863

(3019069) Monocytes/100 leukocytes in Blood

2002

13816

2.00

88.84

8.2

6.3

8.19

8.32

1.10

1876

12984

(3022096) Basophils/100 leukocytes in Blood

1936

13247

1.99

87.57

7.9

6.1

0.65

0.68

1.35

1808

12389

(3006315) Basophils [#/volume] in Blood

2077

14598

1.99

86.52

7.7

6.0

0.04

e9/l

0.04

1809

12661

(3001604) Monocytes [#/volume] in Blood

2070

14584

1.98

85.01

7.8

6.0

0.57

0.56

e9/l

1.38

1810

12659

(3002030) Lymphocytes/100 leukocytes in Blood

2044

14342

1.98

84.91

7.9

6.1

28.64

29.30

2.02

1924

13527

(3018010) Neutrophils/100 leukocytes in Blood

2013

14129

1.96

82.65

7.6

5.9

56.59

56.20

0.80

1893

13309

(3019198) Lymphocytes [#/volume] in Blood

2115

15102

1.96

82.44

7.8

6.0

2.00

1.98

e9/l

0.12

1895

13444

(40760892) CBC W Ordered Manual Differential panel - Blood

1969

13740

1.95

82.00

8.0

6.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2283

16843

1.96

79.46

10.7

8.8

4.24

3.99

e9/l

3.63

1994

14705

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

9.58

66.09

1.1

1.2

0.32

0.29

g/l

1.09

(3023368) Bacteria identified in Blood by Culture

1073

6459

1.94

66.01

5.2

4.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

18.83

65.71

1.0

0.54

0.01

u/ml

0.78

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

9.54

62.54

1.1

1.2

110.52

107.46

0.40

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

261

882

3.11

59.34

1.9

1.8

1.24

1.17

g/l

3.10

252

828

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

725

3978

2.03

57.16

2.2

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

252

853

3.10

57.10

1.9

1.8

0.24

0.23

g/l

1.25

242

802

(3013707) Erythrocyte sedimentation rate by Westergren method

2618

21289

1.83

55.46

5.1

3.8

11.58

10.69

mm/h

2.89

2453

19801

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2606

21201

1.82

54.64

9.2

7.0

78.87

77.21

u/l

0.96

2493

20000

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1020

6429

1.82

52.12

2.5

1.9

1.01

1.08

mg/l

0.28

736

4806

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1854

13824

1.70

51.94

7.0

5.8

10.71

11.36

umol/l

1.03

1767

13058

(3037522) Nuclear Ab [Titer] in Serum

718

4093

1.94

50.02

1.5

1.3

489.18

544.99

titre

0.35

170

826

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1599

11697

1.66

46.31

7.0

5.9

1.22

mmol/l

0.92

1498

10703

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1727

12957

1.64

44.69

7.9

6.5

1.22

mmol/l

1.48

1518

11059

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3328

29969

2.35

44.50

19.2

11.9

20.24

21.73

mg/l

1.94

2808

23148

(3031040) Bacteria [#/volume] in Urine by Automated count

2361

19262

1.65

42.63

5.5

4.1

294.30

1949.56

e6/l

2.71

236

(3022217) INR in Platelet poor plasma by Coagulation assay

1507

11105

1.61

40.72

14.0

12.0

1.19

inr

0.05

465

3354

(3037467) Urinalysis macro (dipstick) panel - Urine

2439

20178

1.64

40.50

5.2

4.0

—

(40758558) Short blood count panel - Blood

1085

7391

1.67

40.03

8.1

6.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2010

15916

1.59

39.66

5.3

4.6

6.62

6.50

mmol/l

1.61

1896

14659

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

13.98

39.07

1.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1289

9236

1.61

38.53

3.9

3.2

54.40

95.86

ng/l

0.31

747

5410

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

749

4675

1.76

37.79

4.2

3.4

157.70

439.46

ng/l

3.92

492

3213

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1184

8447

1.60

35.31

3.0

2.5

63.84

57.96

u/l

0.35

1104

7826

(3002582) Erythrocytes [#/volume] in Urine

1142

8080

1.60

35.26

3.9

3.1

126.91

89.89

e6/l

0.15

898

6142

(3030467) Casts [#/volume] in Urine by Automated count

1065

7422

1.62

34.95

3.8

3.0

0.26

0.38

e6/l

1.73

830

5589

(3024561) Albumin [Mass/volume] in Serum or Plasma

1487

11201

1.56

34.89

5.4

4.7

36.12

36.18

g/l

0.16

1404

10436

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

360

1815

2.09

34.63

1.9

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

137

5.19

33.96

1.2

13.45

24.70

u/ml

0.21

(3019550) Sodium [Moles/volume] in Serum or Plasma

3245

29494

1.96

33.49

19.2

13.1

139.46

139.60

mmol/l

3.01

3181

28686

(36304419) Bacteria [Presence] in Urine

1053

7380

1.60

33.48

3.7

2.9

—

(3018095) Leukocytes [#/volume] in Urine

1326

9829

1.55

32.90

4.6

3.5

61.63

92.63

e6/l

1.08

959

6686

(3023103) Potassium [Moles/volume] in Serum or Plasma

3250

29593

1.95

32.79

19.4

13.2

3.93

3.94

mmol/l

1.92

3181

28724

(3033658) Prothrombin time (PT) actual/Normal

995

6956

1.59

31.64

4.6

3.9

92.98

93.36

0.18

973

6768

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

477

2735

1.86

31.46

2.1

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

834

5607

1.63

31.08

3.0

2.5

7.30

7.09

e6/l

0.14

768

5028

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1279

9513

1.53

30.70

3.4

3.1

28.75

31.89

u/l

3.22

1212

9060

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

790

5280

1.63

30.01

1.3

23.65

27.89

iu/ml

0.63

236

1679

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1043

7468

1.56

29.51

2.3

2.1

151.85

206.50

u/l

1.94

987

7047

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

475

2772

1.82

29.49

2.1

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

944

6623

1.58

29.15

1.7

1.4

2.15

2.20

g/l

0.48

583

4079

(3018418) pH of Serum or Plasma

1050

7550

1.55

29.07

4.1

3.8

7.40

0.01

169

1425

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1370

10461

1.50

28.44

2.1

1.9

97.18

96.98

pmol/l

0.05

735

5448

(3026493) Urate [Moles/volume] in Serum or Plasma

952

6724

1.56

28.43

3.0

2.4

1123.57

4442.01

umol/l

5.02

853

5995

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

744

4984

1.62

27.73

1.4

1.3

12.83

9.88

u/ml

0.44

267

2024

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

279

1389

2.09

27.60

1.9

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

646

4195

1.66

27.21

3.3

2.8

3.86

3.31

e6/l

0.42

339

2214

(3026782) Osmolality of Urine

782

5326

1.60

27.14

3.3

2.7

533.33

537.24

mosm/kgh2o

0.19

703

4579

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

678

4469

1.64

26.89

3.2

2.6

1.00

1.30

e6/l

0.83

375

2482

(3042936) Bacteria identified in Isolate by Culture

586

3722

1.69

26.84

2.2

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

533

3302

1.72

26.76

1.9

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

384

2160

1.87

26.70

3.4

2.8

10.36

10.43

g/l

0.12

356

1985

(3009445) Proteinase 3 Ab [Units/volume] in Serum

229

1071

2.21

26.56

1.2

1.5

29.90

8.39

u/ml

—

(3026008) Bacteria identified in Urine by Culture

1137

8468

1.50

26.12

3.4

2.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

317

1694

1.95

25.72

2.0

1.8

1.30

1.36

g/l

0.23

291

1562

(3021589) Normoblasts [#/volume] in Blood

1643

13182

1.45

25.65

11.7

8.8

0.01

0.00

e9/l

0.53

1323

10723

(3027231) Wheat IgE Ab [Units/volume] in Serum

5.72

25.52

1.1

1.93

11.06

u/ml

0.65

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1523

12054

1.45

25.51

2.6

2.3

73.77

75.45

nmol/l

1.57

1398

11042

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

101

5.21

25.49

1.3

1.2

9.29

18.98

u/ml

0.51

(3036481) Cortisol [Moles/volume] in Serum or Plasma

463

2808

1.74

24.99

2.5

2.1

348.68

375.83

nmol/l

1.95

440

2573

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

222

3.66

24.87

1.4

1.2

4.09

2.55

u/ml

0.38

108

(4200892) Spirometry reversibility

333

1840

1.89

24.41

1.5

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

627

4159

1.61

23.97

2.4

116.85

114.52

ug/g

0.06

510

3293

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

851

6067

1.53

23.68

3.7

3.0

1089.53

1206.68

ng/l

0.43

707

5073

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

312

1710

1.90

23.42

6.6

4.5

5.09

5.14

kpa

0.59

296

1642

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2678

23763

1.49

23.23

4.7

4.1

14.55

14.57

pmol/l

0.20

2484

21893

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

161

687

2.41

23.13

1.3

8.20

10.62

iu/ml

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

616

4102

1.60

23.10

4.4

3.9

0.82

mmol/l

0.34

578

3864

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2984

27150

1.56

22.37

15.5

10.7

88.42

87.47

ml/min/173m2

1.44

2523

22094

(3009343) pH of Capillary blood

306

1693

1.88

22.30

6.6

4.5

7.42

7.41

0.99

179

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

137

555

2.53

22.02

6.3

327.13

584.25

iu/ml

0.66

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

186

865

2.21

21.87

1.5

688.00

265.83

titre

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

179

820

2.24

21.83

1.2

34.76

36.92

u/ml

0.04

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

209

1019

2.12

21.81

2.3

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

298

1650

1.88

21.65

6.6

4.5

1.72

1.53

mmol/l

0.44

220

1215

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

7.17

21.61

1.1

1.0

0.38

0.06

u/ml

0.74

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

192

914

2.16

21.30

2.1

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1018

7674

1.45

21.06

1.4

1.3

1.52

1.66

u/ml

0.16

248

2031

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1001

7524

1.46

21.02

1.8

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

487

3142

1.64

20.61

3.1

2.9

5.85

7.08

umol/l

1.04

417

2698

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

136

570

2.44

20.35

1.2

1.87

3.70

u/ml

0.50

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

420

2619

1.68

20.28

3.0

2.4

33.20

56.65

u/l

0.70

357

2253

(3044640) Blood type and Crossmatch panel - Blood

1155

8981

1.42

19.95

2.8

2.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3344

31478

1.81

19.95

12.8

9.2

26.31

25.75

u/l

1.02

3278

30457

(40768797) Stomach Pathology biopsy report

554

3715

1.58

19.93

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

18.89

19.93

1.0

1.1

0.09

0.14

u/ml

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

941

7064

1.45

19.66

2.4

2.2

2.83

mg/l

0.04

792

6039

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

164

757

2.22

19.65

1.2

5.70

8.19

u/ml

0.43

130

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3015

27712

1.52

19.31

5.7

4.7

1.79

2.07

mu/l

1.78

2836

25835

(40768804) Tissue Pathology biopsy report

1435

11648

1.38

19.03

2.1

2.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

164

769

2.19

18.91

1.1

6.03

6.04

u/ml

0.00

116

424

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

6.20

18.91

1.3

1.0

4.98

0.13

u/ml

0.84

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

143

3.89

18.83

2.1

2.6

764.22

1043.13

u/ml

0.66

143

(3004789) Transferrin [Mass/volume] in Serum or Plasma

553

3757

1.56

18.71

2.6

2.4

2.40

g/l

0.04

504

3488

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

6.24

18.45

1.3

1.0

14.07

0.11

u/ml

0.53

(3021960) Folate [Moles/volume] in Serum or Plasma

781

5717

1.47

18.45

1.6

1.5

19.68

20.67

nmol/l

1.15

670

4947

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2310

20301

1.38

18.37

3.6

3.0

45.38

41.14

u/l

1.77

2192

19182

(3022948) Iron [Moles/volume] in Serum or Plasma

596

4148

1.52

18.01

2.6

2.4

12.87

13.78

umol/l

2.53

556

3880

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

158

746

2.17

17.92

1.2

3.45

3.74

u/ml

0.07

(3010726) Horse dander IgE Ab [Units/volume] in Serum

154

720

2.19

17.90

1.1

2.79

1.96

u/ml

0.48

100

379

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

902

6818

1.43

17.88

2.8

2.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

249

3.05

17.63

1.2

28.15

11.63

u/ml

0.38

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

180

901

2.05

17.53

2.1

1.9

—

(40768443) Skin Pathology biopsy report

204

1077

1.95

17.10

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

321

2.75

16.92

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

508

3462

1.54

16.83

2.7

2.5

21.37

23.43

2.81

441

3000

(3018677) aPTT in Platelet poor plasma by Coagulation assay

555

3856

1.52

16.82

3.2

2.6

29.70

29.59

0.17

540

3740

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

333

2049

1.69

16.81

2.4

21.78

22.03

au/ml

0.02

183

(3019309) Folate [Moles/volume] in Red Blood Cells

611

4339

1.49

16.64

1.7

1097.15

1170.06

nmol/l

1.09

457

3290

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

309

1870

1.71

16.58

1.3

27.94

47.42

au/ml

1.16

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

5.28

16.54

1.2

1.1

1.79

4.21

u/ml

0.60

(3022313) Gas panel - Capillary blood

233

1300

1.85

16.49

7.2

4.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

380

2432

1.63

16.45

2.5

2.4

0.22

g/l

0.30

350

2283

(3011397) Hemoglobin [Presence] in Urine by Test strip

880

6708

1.41

16.42

3.8

3.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

412

2691

1.60

16.41

5.6

4.3

232.36

246.79

u/l

1.38

397

2544

(3009261) Glucose [Presence] in Urine by Test strip

1721

14609

1.34

16.20

4.0

3.4

0.00

estimate

1.06

323

2717

(3015171) Extractable nuclear Ab [Units/volume] in Serum

215

1178

1.88

16.11

1.3

1.62

0.85

u/ml

0.29

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

16.78

16.05

1.0

1.1

0.02

0.07

u/ml

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1691

14341

1.34

15.91

3.4

2.8

112.96

93.21

ug/l

1.38

1575

13438

(3000494) Fungus identified in Specimen by Culture

478

3252

1.54

15.91

1.6

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

215

1183

1.87

15.90

2.2

1.9

39.36

39.05

u/l

0.08

192

1077

(3014111) Lactate [Moles/volume] in Serum or Plasma

341

2142

1.65

15.89

6.4

7.5

1.28

1.35

mmol/l

0.63

335

2088

(3021601) Nitrite [Presence] in Urine by Test strip

1704

14477

1.33

15.80

5.5

4.6

0.00

estimate

0.41

344

2784

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

429

2.44

15.69

3.6

4.0

297.80

1736.85

u/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

1702

14472

1.33

15.62

4.0

3.4

0.00

estimate

1.54

348

2896

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

122

549

2.26

15.60

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

122

549

2.26

15.60

1.5

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

593

4238

1.48

15.57

1.8

1.6

—

(3015736) pH of Urine

1416

11738

1.34

15.40

3.6

3.2

5.81

5.93

1.10

129

1099

(3017354) Segmented neutrophils/100 leukocytes in Blood

210

3.08

15.39

3.9

3.1

57.32

55.26

0.31

185

(3000991) Gas panel - Venous blood

344

2192

1.63

15.13

8.1

8.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

193

3.14

14.93

1.2

101.17

44.91

u/ml

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

773

2.04

14.91

2.0

2.4

2.91

2.94

g/l

0.13

140

708

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

160

815

2.01

14.88

2.0

2.3

3.78

3.57

g/l

1.35

146

751

(3002179) Metamyelocytes/100 leukocytes in Blood

324

2043

1.64

14.85

4.2

4.0

0.53

0.62

0.38

132

609

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

160

816

2.01

14.83

2.0

2.3

7.40

7.34

g/l

0.18

146

751

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

160

816

2.01

14.83

2.0

2.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

144

707

2.08

14.81

2.2

2.4

0.34

0.93

g/l

1.67

122

632

(3020874) Milk IgE Ab [Units/volume] in Serum

253

2.84

14.78

1.3

1.2

18.01

3.49

u/ml

0.59

105

(3015377) Calcium [Moles/volume] in Serum or Plasma

1120

9023

1.35

14.54

3.3

3.2

2.35

mmol/l

0.92

1003

8064

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

140

688

2.08

14.37

1.6

1.3

—

(3023419) Bacteria identified in Sputum by Culture

320

2.60

14.34

3.4

2.7

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

183

3.15

14.25

1.2

2.14

3.58

u/ml

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

6.19

14.19

1.1

3.09

3.26

u/ml

0.02

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

182

988

1.89

14.06

1.4

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

162

846

1.96

14.05

1.2

1.1

2.29

2.74

u/ml

0.25

102

463

(3003458) Phosphate [Moles/volume] in Serum or Plasma

484

3391

1.49

13.93

6.8

6.1

1.07

mmol/l

0.05

453

3172

(3004809) Band form neutrophils/100 leukocytes in Blood

355

2.49

13.89

3.8

3.3

0.88

1.29

0.85

321

(3008401) Mugwort IgE Ab [Units/volume] in Serum

146

740

2.01

13.79

1.1

2.72

1.14

u/ml

0.81

349

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

130

634

2.09

13.63

1.8

2.3

0.00

0.01

g/l

0.41

116

593

(3017181) Myelocytes/100 leukocytes in Blood

342

2233

1.59

13.57

4.8

4.2

0.83

0.92

0.23

142

704

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2524

22929

1.33

13.53

4.1

3.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2753

25336

1.36

13.52

5.7

4.9

39.05

38.65

mmol/mol

1.39

2565

23696

(3021440) Promyelocytes/100 leukocytes in Blood

328

2135

1.59

13.18

4.9

4.3

0.09

0.12

0.25

127

606

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

129

636

2.07

13.15

2.0

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

178

981

1.86

13.13

1.6

1.07

0.32

iu/ml

0.44

198

(3020630) Protein [Mass/volume] in Serum or Plasma

286

1803

1.64

13.11

3.2

2.7

66.84

66.56

g/l

0.26

261

1659

(3013512) EKG study

889

7016

1.35

12.94

4.2

3.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

137

695

2.01

12.92

3.2

2.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

203

1171

1.78

12.90

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

205

1190

1.77

12.75

8.0

4.8

24.69

24.61

mmol/l

0.16

197

1127

(3004588) Protein electrophoresis panel - Serum or Plasma

237

1439

1.69

12.55

3.1

2.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

5.24

12.47

1.3

1.0

0.57

0.74

u/ml

0.09

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

243

1488

1.68

12.47

1.6

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

298

1922

1.60

12.44

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

119

582

2.08

12.41

1.8

2.3

0.00

g/l

-0.00

105

544

(3015076) Soybean IgE Ab [Units/volume] in Serum

221

2.79

12.37

1.1

5.82

2.16

u/ml

0.32

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

143

750

1.94

12.28

1.9

2.3

10.24

10.27

g/l

0.02

128

681

(3000492) Spirometry study

422

2952

1.49

12.17

1.5

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

100

461

2.20

12.14

2.0

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

100

461

2.20

12.14

2.0

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

142

747

1.94

12.09

2.3

2.0

11.75

11.33

mg/l

0.21

131

696

(3021447) Carbon dioxide [Partial pressure] in Venous blood

352

2376

1.53

12.04

5.3

4.5

5.85

5.83

kpa

0.14

343

2306

(3002032) Base excess in Venous blood by calculation

350

2360

1.53

12.03

5.4

4.6

1.97

1.80

mmol/l

0.40

309

1959

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

170

950

1.83

12.02

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

100

463

2.19

12.01

1.5

1.7

0.82

0.74

g/l

0.23

352

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1584

13648

1.29

11.99

3.1

2.5

—

(40761511) CBC panel - Blood by Automated count

3301

31509

1.53

11.96

15.9

11.1

—

(3025159) Blasts/100 leukocytes in Blood

311

2046

1.57

11.93

4.9

4.3

0.17

0.41

0.49

110

511

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

117

579

2.05

11.84

1.8

2.3

0.00

g/l

-0.00

104

543

(3017732) Neutrophils [#/volume] in Blood

310

2043

1.57

11.80

3.3

2.6

4.56

4.96

e9/l

0.29

249

1723

(3022145) Colonoscopy Study observation

425

2997

1.47

11.76

1.4

1.3

—

(3044889) 12 lead EKG panel

2112

18904

1.28

11.63

3.6

3.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

126

646

1.98

11.57

1.8

2.2

38.43

38.02

g/l

0.32

112

579

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

220

2.71

11.36

2.6

3.1

603.80

565.16

e6/l

0.21

187

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

282

1841

1.58

11.18

2.1

2.2

6.86

6.80

ug/l

0.02

237

1627

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

458

2.15

11.12

2.1

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

217

2.70

11.10

2.6

3.1

0.21

e9/l

0.01

188

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

123

635

1.97

11.09

2.0

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

152

846

1.83

10.91

2.0

1.31

1.74

ug/l

0.27

129

750

(3019225) pH of Specimen

356

2460

1.50

10.88

5.7

3.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

972

7937

1.31

10.85

2.1

2.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

476

2.11

10.84

1.2

1.3

3.40

4.31

u/ml

0.47

205

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

334

2.33

10.83

1.7

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

319

2157

1.53

10.81

9.5

7.9

8.29

8.36

mmol/l

0.07

303

2068

(3005988) Vibrio sp identified in Specimen by Organism specific culture

335

2.33

10.76

1.7

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

366

2549

1.48

10.76

1.3

1.2

106.85

164.03

iu/ml

2.81

122

968

(3021879) Hepatitis B virus core Ab [Presence] in Serum

386

2718

1.47

10.73

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

274

2.47

10.73

5.6

4.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

336

2.32

10.69

1.7

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

160

912

1.79

10.63

3.7

3.1

183.34

177.87

0.34

152

875

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

5.02

10.51

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

333

2.31

10.46

1.7

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

114

586

1.98

10.43

1.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

340

2.29

10.41

1.7

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

334

2.30

10.39

1.7

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

109

553

2.00

10.35

1.2

1.1

8.66

5.20

u/ml

0.65

235

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

196

1196

1.68

10.22

8.1

10.2

24.08

24.30

mmol/l

0.40

191

1164

(3000570) Elastase.pancreatic [Mass/mass] in Stool

137

757

1.84

10.09

1.3

1.4

320.90

294.99

ug/g

0.76

404

(3014133) Dog dander IgE Ab [Units/volume] in Serum

115

601

1.94

10.04

1.2

1.1

4.03

4.17

u/ml

0.04

289

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

287

1928

1.53

10.02

3.7

3.9

89.09

78.53

ng/l

0.73

257

1692

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

121

644

1.91

10.01

1.2

36.41

42.16

u/ml

0.14

(4062490) Immunoglobulin typing, IgG

284

2.38

9.95

1.4

—

(3021901) Oxygen saturation in Capillary blood

399

2.16

9.93

3.4

2.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

279

2.39

9.87

1.3

1.4

2.96

2.87

g/l

0.19

193

(3024139) IgG subclass 3 [Mass/volume] in Serum

279

2.39

9.87

1.3

1.4

0.34

0.39

g/l

0.70

191

(3036489) Thrombin time

188

1146

1.68

9.85

3.1

2.8

20.80

21.51

1.27

168

988

(3000475) Leukocytes [#/volume] in Synovial fluid

112

584

1.95

9.85

1.9

1.7

23007.78

11188.56

e6/l

0.69

421

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

599

4620

1.36

9.83

3.0

2.8

2.43

2.44

mmol/l

1.34

528

4051

(3027135) IgG subclass 1 [Mass/volume] in Serum

280

2.38

9.79

1.3

1.4

6.57

6.52

g/l

0.04

194

(3011841) English Walnut IgE Ab [Units/volume] in Serum

3.99

9.76

1.1

0.37

8.78

u/ml

0.71

(3025941) Bacteria identified in Stool by Culture

270

1805

1.54

9.65

1.3

1.2

—

(3021788) Differential panel - Synovial fluid

458

2.06

9.61

1.5

1.6

—

(3011412) CD3 cells [#/volume] in Blood

296

2.32

9.53

2.5

2.9

1.44

1.30

e9/l

0.55

267

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

184

1127

1.67

9.48

1.2

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

3478

33798

1.72

9.46

26.7

17.7

39.98

40.40

1.18

3340

31994

(36660697) Celiac disease serology panel - Serum

383

2757

1.44

9.46

1.3

1.2

—

(3010813) Leukocytes [#/volume] in Blood

3483

33860

1.74

9.46

26.7

17.6

7.01

6.71

e9/l

5.28

3423

32973

(3020961) Endomysium IgA Ab [Titer] in Serum

257

1707

1.54

9.46

1.2

1.1

289.00

137.58

titre

—

(3007461) Platelets [#/volume] in Blood

3480

33827

1.72

9.40

26.7

17.6

261.75

259.16

e9/l

1.51

3430

33012

(3028626) Oxygen [Partial pressure] in Capillary blood

139

791

1.79

9.32

8.7

5.2

8.94

8.91

kpa

0.06

134

772

(3052851) Hemolysis interference index of Serum or Plasma

140

800

1.78

9.26

3.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

178

1088

1.67

9.25

1.5

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

260

1742

1.53

9.20

9.9

8.5

24.34

24.75

mmol/l

1.09

260

1734

(3024731) MCV [Entitic volume]

3481

33855

1.71

9.17

26.6

17.5

90.20

90.26

0.30

3457

33431

(3035941) MCH [Entitic mass]

3481

33855

1.71

9.17

26.5

17.5

30.05

30.09

0.84

3457

33428

(3003327) Ova and parasites identified in Stool by Light microscopy

183

1131

1.65

9.12

1.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

3482

33874

1.71

9.07

26.8

17.7

134.41

135.02

g/l

1.85

3461

33442

(3026361) Erythrocytes [#/volume] in Blood

3481

33862

1.71

9.06

26.7

17.6

4.50

4.51

e12/l

0.63

3421

32985

(3027945) Reticulocytes/100 erythrocytes in Blood

375

2717

1.42

8.93

3.0

1.76

1.74

0.11

339

2424

(3002173) Hemoglobin [Mass/volume] in Arterial blood

302

2104

1.47

8.85

7.1

8.5

121.54

121.83

g/l

0.08

289

2042

(3049717) Cytology report of Urine Cyto stain

126

708

1.81

8.83

2.3

2.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

358

2582

1.43

8.74

6.7

7.6

4.99

5.10

kpa

1.42

338

2458

(3027801) Oxygen [Partial pressure] in Arterial blood

358

2583

1.43

8.72

6.7

7.6

12.17

12.86

kpa

1.66

338

2460

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

315

2.21

8.68

2.0

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

130

2.94

8.65

1.1

9.16

8.71

u/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

109

3.14

8.64

1.2

1.1

3.60

4.33

iu/ml

—

(3002385) Erythrocyte distribution width [Ratio]

2816

26498

1.28

8.56

21.6

14.4

14.50

14.67

0.41

2791

26012

(3016502) Oxygen saturation in Arterial blood

320

2270

1.45

8.55

6.9

8.2

95.56

95.73

0.16

306

2186

(3003396) Base excess in Arterial blood by calculation

356

2577

1.42

8.52

6.7

7.7

0.67

1.01

mmol/l

0.81

287

2005

(3010838) Calcium [Moles/time] in 24 hour Urine

494

1.95

8.48

2.0

1.9

5.05

5.23

mmol/24h

0.26

441

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

489

1.95

8.38

1.3

1.2

1.91

3.26

u/ml

1.00

155

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2907

27487

1.29

8.36

4.6

3.9

5.86

5.77

mmol/l

2.38

2691

25349

(3009508) Creatinine [Moles/volume] in Urine

946

7915

1.26

8.35

3.4

3.3

7.73

7.58

mmol/l

0.38

799

6824

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

212

1389

1.56

8.31

1.9

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

114

636

1.82

8.21

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.21

8.20

1.8

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.21

8.20

1.8

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

356

2.10

8.19

1.2

—

(1616796) Gas panel - Central venous blood

100

537

1.89

8.12

3.8

3.4

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

4.54

8.11

1.4

1.0

2.90

5.03

u/ml

0.54

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

126

2.88

7.89

1.7

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

238

2.33

7.88

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

13.04

7.87

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

335

2.11

7.87

1.1

92.22

95.19

0.36

318

(3002256) Pathology report gross observation

463

3547

1.35

7.85

1.3

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

121

2.91

7.84

1.1

1.0

14.93

15.47

u/ml

0.03

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

136

811

1.70

7.80

2.6

2.4

168.33

390.91

ug/l

2.36

123

750

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

717

5846

1.28

7.75

2.6

2.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

222

2.36

7.69

1.1

1.3

230.00

197.00

titre

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

469

1.92

7.67

1.1

117.57

116.64

0.09

428

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

123

2.86

7.63

1.7

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

279

1971

1.45

7.63

1.1

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

280

2.20

7.62

2.2

1.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

18.38

7.59

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

464

1.92

7.58

1.9

1.6

—

(44813793) Dust mix specific IgE antibody measurement

243

2.28

7.53

1.1

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

237

2.30

7.51

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

237

2.30

7.51

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

4.24

7.47

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

136

2.74

7.43

1.5

1.4

47.00

19.04

u/ml

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

330

2.08

7.39

2.2

2.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.20

7.38

1.8

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

781

6472

1.26

7.35

1.8

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

413

1.96

7.34

1.2

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

150

934

1.63

7.32

3.7

3.6

3.68

3.53

g/l

0.61

143

886

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.31

7.23

2.5

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

287

2060

1.43

7.21

3.3

4.54

pmol/l

0.00

251

1845

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

100

3.02

7.18

2.2

7.71

9.73

mg/l

0.89

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

236

2.26

7.14

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

236

2.26

7.14

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

236

2.26

7.14

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

648

5266

1.28

7.14

2.5

2.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

376

1.99

7.11

1.8

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

255

1796

1.45

7.10

4.0

3.0

144.79

178.90

ng/l

1.08

225

1613

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

505

1.84

7.03

1.1

0.61

0.50

u/ml

0.10

162

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

126

759

1.68

7.00

1.1

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

211

1436

1.50

6.98

7.8

9.6

0.66

0.69

0.43

211

1428

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

494

1.84

6.89

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

119

711

1.70

6.82

5.2

4.6

0.33

0.35

u/ml

0.38

397

(3007566) Smooth muscle Ab [Titer] in Serum

128

781

1.66

6.79

1.2

1.3

72.73

85.16

titre

0.28

(3024891) Influenza virus A+B Ag [Presence] in Specimen

144

907

1.61

6.73

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

277

2002

1.42

6.70

5.1

4.1

4.77

4.76

kpa

0.03

268

1938

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

506

4015

1.30

6.68

1.8

1.43

1.40

0.37

433

3599

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

457

3577

1.32

6.67

2.0

—

(3024928) Oxygen saturation in Venous blood

523

1.80

6.60

4.4

4.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

209

1438

1.48

6.57

7.9

9.5

1.37

1.36

0.03

209

1429

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

332

2.01

6.56

1.8

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

332

2.01

6.56

1.8

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.96

6.53

3.5

2.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

838

7085

1.24

6.51

4.1

3.9

10.72

9.37

mg/mmol

0.31

498

4497

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

227

2.22

6.47

2.0

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

227

2.22

6.47

2.0

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

227

2.22

6.47

2.0

1.4

—

(3037121) Protein [Mass/volume] in Urine

146

937

1.58

6.34

3.7

3.6

0.28

0.31

g/l

0.18

422

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.95

6.29

1.7

2.79

1.01

mg/l

0.59

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

131

2.61

6.29

2.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

131

2.61

6.29

2.4

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

400

3099

1.33

6.27

4.4

4.0

30.70

32.35

2.55

301

2186

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

126

2.63

6.21

1.3

1.2

—

(3012516) Albumin [Mass/volume] in Urine

799

6752

1.24

6.20

3.6

3.3

382.00

314.04

mg/l

0.16

486

4287

(3011985) Renin [Units/volume] in Plasma

360

1.93

6.20

1.7

1.6

79.70

45.93

mu/l

0.49

323

(3023520) Reticulocytes [#/volume] in Blood

267

1947

1.40

6.16

3.0

2.8

72.15

70.95

e9/l

0.20

195

1442

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

368

1.92

6.15

1.8

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

293

2.03

6.10

1.9

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

178

1205

1.50

6.08

8.7

10.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

315

1.99

6.02

1.6

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

446

1.81

5.88

1.8

1.4

—

(3045414) Leukocytes [Presence] in Urine

188

1297

1.47

5.86

2.1

1.8

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.79

5.83

1.7

0.28

0.87

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.79

5.83

1.7

2.28

2.07

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.79

5.83

1.7

2.12

3.50

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.79

5.83

1.7

0.87

0.69

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.79

5.83

1.7

1.40

2.46

mg/l

—

(3042631) Mycobacterium sp identified in Specimen

265

2.05

5.78

3.2

2.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

219

2.16

5.75

3.0

2.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

293

2.00

5.74

1.4

1.6

55.97

56.87

0.06

188

(40767503) Oxygen content in Capillary blood by calculation

494

1.76

5.73

3.2

2.3

16.87

16.52

0.35

236

(3027315) Oxygen [Partial pressure] in Blood

569

1.71

5.73

3.8

8.86

8.85

kpa

0.01

562

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

524

1.74

5.72

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

203

1430

1.44

5.69

8.1

9.7

93.92

94.03

0.10

203

1423

(3023183) Ammonium ion [Moles/volume] in Plasma

534

1.72

5.64

2.3

2.8

32.10

34.16

umol/l

0.43

492

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

833

7143

1.22

5.54

1.7

1.6

1.47

1.37

mmol/l

1.88

723

6140

(3000060) B lymphocytes [#/volume] in Blood

122

2.55

5.53

2.7

3.6

319.38

274.75

e6/l

0.22

(3013290) Carbon dioxide [Partial pressure] in Blood

571

1.68

5.41

3.8

4.80

5.00

kpa

2.14

564

(3012501) Base excess in Blood by calculation

571

1.68

5.41

3.8

2.49

2.44

mmol/l

0.06

363

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.19

5.38

1.4

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

130

2.47

5.36

2.3

1.4

13.12

12.94

u/l

0.05

124

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

278

2091

1.36

5.33

2.4

2.2

3058.77

5961.12

u/l

1.71

820

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

528

4332

1.26

5.30

1.6

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

388

1.82

5.28

1.1

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

412

1.79

5.20

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

110

695

1.60

5.16

1.8

1.6

3.58

3.65

mmol/l

0.37

649

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

183

2.20

5.15

1.4

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

377

1.82

5.14

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

225

2.06

5.01

1.0

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

151

1032

1.48

4.99

1.7

1.9

1.55

1.49

g/l

0.43

136

906

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

644

5435

1.22

4.97

1.6

22677017.70

37525031.77

pmol/l

0.27

538

4573

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2842

27221

1.20

4.95

3.9

3.5

1.34

1.26

mmol/l

7.63

2667

25337

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

213

2.08

4.93

3.9

3.5

—

(3003338) MCHC [Mass/volume]

2792

26701

1.20

4.93

22.2

15.0

332.38

332.70

g/l

0.84

2773

26493

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

157

1085

1.47

4.91

3.8

3.4

1.27

1.26

0.02

157

1079

(3005011) Chlamydia sp Ab [Titer] in Serum

3.23

4.89

1.4

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.34

4.88

1.2

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

137

924

1.50

4.84

1.3

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2958

28466

1.21

4.76

4.4

3.9

4.69

4.74

mmol/l

1.48

2794

26754

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.21

4.76

1.4

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2991

28818

1.22

4.74

4.7

4.2

2.83

mmol/l

0.18

2808

26928

(3045424) Erythrocytes [Presence] in Urine

471

1.69

4.68

1.6

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

143

982

1.47

4.64

1.1

1.94

5.12

u/ml

1.51

145

(40761535) Cells panel - Urine sediment

275

2111

1.33

4.63

4.0

3.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.76

4.61

4.2

3.6

—

(40757373) Influenza virus identified in Isolate

3.34

4.60

1.7

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

233

1.99

4.59

2.6

2.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2937

28283

1.20

4.49

4.3

3.8

1.43

1.49

mmol/l

10.63

2754

26476

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

342

1.80

4.49

1.7

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

136

931

1.48

4.49

1.3

1.1

—

(3044941) Cell count panel - Synovial fluid

403

1.73

4.43

1.6

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

557

1.61

4.40

3.3

3.8

58.53

56.46

0.92

557

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

112

2.42

4.38

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

133

913

1.47

4.34

1.3

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

638

1.57

4.34

1.9

1.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

179

1299

1.40

4.33

1.2

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

11.69

4.27

1.0

—

(3019060) Gas panel - Arterial blood

194

1434

1.37

4.21

3.9

4.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

342

1.77

4.20

1.2

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

588

1.58

4.19

4.6

3.4

1.34

1.57

ratio

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

355

2859

1.27

4.18

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

518

1.62

4.17

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

177

1293

1.39

4.13

2.4

2.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

606

1.57

4.13

4.8

3.4

33.87

39.79

mg/l

0.41

503

(21494434) Karyotype in Bone marrow

208

1.98

4.11

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

529

1.60

4.08

1.1

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

251

1.88

4.06

1.7

1.3

5.73

5.23

umol/l

0.33

237

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

634

1.54

4.02

1.5

1.4

91.46

111.39

u/ml

0.96

126

(3045142) Bone marrow Pathology biopsy report

288

1.82

4.02

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

109

732

1.50

3.99

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

111

2.35

3.99

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

604

1.55

3.97

4.8

3.4

43.22

62.23

mg/l

0.81

499

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

261

1.85

3.94

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

112

759

1.49

3.93

2.9

2.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

283

1.81

3.93

2.0

2.1

9.73

25.06

mg/l

3.45

(3028433) Virus identified in Specimen by Culture

101

2.39

3.81

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

167

2.05

3.74

2.4

2.8

40.94

43.56

0.29

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

101

679

1.50

3.70

1.5

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

109

2.30

3.68

2.8

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

109

2.30

3.68

2.8

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1230

11214

1.15

3.65

4.1

3.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.69

3.65

1.3

1.2

476.08

284.23

pmol/l

0.75

(3025018) Bordetella pertussis Ab [Titer] in Serum

232

1.86

3.64

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

183

1.98

3.62

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

276

1.79

3.62

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

110

2.28

3.61

2.8

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

167

1238

1.37

3.60

3.0

2.7

0.33

0.24

e6/l

0.44

161

1199

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.58

3.54

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.45

3.54

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

124

2.19

3.54

1.1

—

(3008898) HLA-B27 [Presence]

177

1329

1.35

3.53

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

264

1.79

3.51

1.2

1.1

42.60

76.72

u/l

2.57

242

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

221

1.86

3.49

1.4

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

221

1717

1.31

3.48

2.4

2.1

9.92

11.68

nmol/l

2.48

196

1555

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

193

1.93

3.47

1.1

—

(3011648) Oxygen content in Venous blood

208

1.88

3.43

6.8

5.5

11.60

11.39

0.12

208

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

113

2.22

3.41

1.1

89.63

90.40

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

245

1.81

3.39

1.1

4.95

10.06

iu/ml

1.49

(3028679) Herpes simplex virus Ab [Presence] in Serum

209

1.88

3.39

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

167

1.99

3.38

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

145

1063

1.38

3.37

3.4

3.3

25.02

25.23

mmol/l

0.36

140

1027

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

224

1.84

3.36

1.4

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

111

778

1.44

3.34

1.8

1.6

484.27

504.46

mg/l

0.14

733

(3034274) Bile acid [Moles/volume] in Serum --fasting

648

1.48

3.29

2.5

2.4

4.89

5.96

umol/l

0.58

477

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

331

1.67

3.26

1.1

1.3

—

nmol/l

—

(3048879) Bone marrow aspiration report

2.67

3.22

3.4

1.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

610

1.49

3.22

1.5

1.4

21.28

23.70

u/l

0.26

522

(3050794) Legionella sp Ab [Presence] in Serum

4.18

3.19

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.86

3.19

1.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

110

2.19

3.18

1.1

1.3

80.88

89.20

—

(3041096) Erythrocytes [Presence] in Urine by Automated

901

8115

1.15

3.12

3.5

3.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

317

2612

1.23

3.10

3.6

3.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

454

1.55

3.08

1.7

1.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.81

3.08

1.6

1.5

36.12

76.40

ng/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

246

1.76

3.07

1.3

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

338

1.64

3.03

1.4

259.35

337.47

pmol/l

1.42

298

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

370

1.60

3.00

1.1

1.58

1.48

g/l

1.12

333

(1002224) Polysomnography panel

166

1269

1.32

2.98

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

10.01

2.98

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

623

1.46

2.93

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

203

1601

1.28

2.90

1.7

1.6

320.19

302.41

mu/l

0.36

180

1442

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

280

2294

1.24

2.90

3.6

4.1

11.67

33.05

ug/l

0.77

216

1805

(3051651) Icteric interference index of Serum or Plasma

170

1.89

2.90

3.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

236

1.75

2.88

1.1

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

4.10

2.88

1.0

1.3

—

2.62

—

(4094501) Cardiovascular stress test using bicycle ergometer

668

1.43

2.86

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

267

1.69

2.85

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

368

1.59

2.83

2.2

3.0

69.65

39.27

u/ml

0.17

363

(3003740) Influenza virus B Ag [Presence] in Specimen

620

1.45

2.82

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

505

1.50

2.81

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

530

1.48

2.80

2.6

2.2

130.22

130.81

g/l

0.07

392

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

680

1.42

2.78

1.4

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

697

1.42

2.78

2.0

1.8

430.66

6496.55

e6/l

0.59

555

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

581

1.46

2.76

2.3

2.4

0.95

0.82

nmol/l

0.71

497

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

258

2107

1.24

2.76

2.8

2.5

74.52

71.52

ml/min/173m2

0.50

101

811

(3051611) Lipemic interference index of Serum or Plasma

270

1.68

2.74

3.3

3.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

120

886

1.37

2.74

5.0

5.1

1.73

1.63

0.48

106

823

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

225

1.74

2.73

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

263

1.68

2.72

1.2

1.4

—

titre

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.22

2.67

1.4

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.28

2.67

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

190

1.80

2.66

3.0

2.8

42347.06

39844.65

ug/l

0.44

190

(3019150) Specific gravity of Urine by Refractometry

706

6323

1.14

2.63

4.1

3.7

1.02

kg/l

0.36

104

941

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.66

2.62

1.1

2.0

—

(3004451) EKG impression Narrative

2.16

2.60

1.4

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

698

1.40

2.60

1.9

1.7

44.14

32.11

e6/l

0.13

527

(1761868) Lipid panel - Serum or Plasma

1019

11070

0.89

2.59

2.6

2.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

423

3651

1.18

2.57

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

114

2.02

2.56

2.3

2.4

—

(4035726) Immunohistochemistry procedure

270

2237

1.22

2.55

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

135

1.93

2.55

1.1

195.90

195.35

iu/ml

0.00

135

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

551

1.44

2.52

1.8

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

157

1.85

2.52

1.4

2.0

160.24

130.83

0.79

152

(3022621) pH of Urine by Test strip

229

1867

1.24

2.52

2.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

136

1.92

2.50

5.7

2.1

276.62

156.95

umol/l

0.38

(3006922) Hepatitis E virus Ab [Presence] in Serum

202

1.74

2.48

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

147

1139

1.30

2.45

1.5

10.73

9.82

u/l

0.32

119

901

(40768795) Lymph node Pathology biopsy report

249

1.65

2.43

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

152

1.85

2.42

1.3

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.90

2.41

2.3

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

515

1.45

2.40

1.1

—

(3036603) Volume of Urine

167

1.80

2.40

1.4

2299.50

1961.63

0.71

162

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

182

1.76

2.39

1.9

3.90

3.59

mg/l

0.12

174

(3014148) Varicella zoster virus Ab [Titer] in Serum

500

1.45

2.37

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.12

2.36

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.12

2.36

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.04

2.35

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

577

1.41

2.33

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

105

2.01

2.30

1.0

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

129

992

1.31

2.29

4.5

3.7

47.86

50.03

0.45

129

982

(40760888) Immunoglobulin light chains.free panel - Serum

454

1.46

2.29

5.5

3.5

—

(3016018) Differential panel - Cerebral spinal fluid

333

1.54

2.27

1.9

1.8

—

(3034426) Prothrombin time (PT)

106

1.99

2.25

1.0

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

224

1.66

2.24

1.2

1.3

1.87

1.92

mmol/l

0.20

208

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

234

1.63

2.16

4.1

2.6

—

(3027008) Opiates [Presence] in Urine

226

1874

1.22

2.16

1.8

2.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.69

2.15

2.1

1.4

48.57

45.05

umol/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.00

2.14

1.0

1.2

—

(3019174) dRVVT (LA screen)

3.00

2.14

1.0

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

3.00

2.14

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.30

2.14

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

428

1.46

2.13

3.2

3.7

169.15

1017.91

u/ml

0.79

399

(3028707) Methadone [Presence] in Urine by Screen method

106

802

1.33

2.13

2.3

2.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

647

1.37

2.13

1.2

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

1.77

2.13

1.1

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

172

1388

1.25

2.12

5.9

6.9

24.49

24.41

mmol/l

0.11

157

1311

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

496

1.42

2.10

3.2

2.8

—

(3028300) Cannabinoids [Presence] in Urine

226

1880

1.22

2.10

1.8

2.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

547

1.40

2.09

1.1

1.51

3.09

u/ml

1.44

273

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

316

1.53

2.08

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

209

1727

1.22

2.07

1.8

2.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.26

2.07

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.26

2.07

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.26

2.07

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

532

1.40

2.06

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

840

7716

1.12

2.05

4.5

3.7

0.00

estimate

1.74

331

2726

(3042111) Morphology [Interpretation] in Bone marrow Narrative

366

1.48

2.05

2.1

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.00

2.04

15.0

6.1

—

(3000764) Benzodiazepines [Presence] in Urine

223

1861

1.21

2.01

1.8

2.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.23

2.00

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

111

1.90

2.00

1.1

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

178

1454

1.24

1.98

1.9

2.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

272

1.55

1.97

1.2

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

114

883

1.30

1.97

5.1

5.2

0.89

0.91

0.24

101

821

(3010144) Erythrocytes [#/volume] in Synovial fluid

217

1.62

1.97

1.7

1.4

171683.41

98835.00

e6/l

0.17

149

(3011288) Drugs identified in Urine by Screen method

158

1276

1.25

1.95

1.9

3.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

187

1.66

1.93

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

234

1.59

1.92

1.1

1.0

295.50

294.00

mg/l

0.04

211

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

104

800

1.31

1.90

3.1

3.7

234.92

1912.29

u/ml

0.72

678

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

128

1.80

1.89

1.9

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

128

1.80

1.89

1.9

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

181

1.66

1.88

1.7

1.5

—

(3006462) Nitrate [Presence] in Urine

136

1.77

1.87

3.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

548

4939

1.13

1.86

1.7

—

(3037756) Immunofixation for Serum or Plasma

417

1.42

1.84

3.1

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

190

1.64

1.84

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

1.86

1.81

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

736

1.31

1.81

4.8

6.1

1.40

1.25

mmol/l

0.80

638

(3024932) HLA-DR beta [Type]

101

1.89

1.80

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.06

1.80

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

241

2050

1.19

1.80

1.4

30.05

25.29

iu/l

1.24

202

1716

(3027944) Amphetamines [Presence] in Urine

219

1848

1.20

1.79

1.8

2.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

279

1.51

1.79

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

747

1.31

1.78

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

146

1.72

1.77

1.6

1.5

1.23

1.31

nmol/l

0.13

116

(3024471) HLA-A [Type]

102

1.87

1.76

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

147

1.71

1.73

1.9

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

265

1.52

1.73

1.1

—

(3008295) Osmolality of Serum or Plasma

290

1.49

1.72

1.6

1.4

282.48

280.26

mosm/kgh2o

0.30

220

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

415

1.40

1.71

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

218

1.56

1.70

1.6

1.5

23.46

36.50

1.51

138

(3044242) Glucose [Moles/volume] in Arterial blood

118

1.78

1.70

2.3

2.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1236

0.78

1.66

1.7

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

180

1.62

1.66

1.8

1.5

—

(3042733) HLA Ab [Presence] in Serum

1.86

1.66

3.9

4.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

529

1.35

1.65

1.9

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.80

1.65

1.9

4.5

—

(3030313) Adrenal Ab [Titer] in Serum

2.44

1.64

1.0

—

(3044927) Protein electrophoresis panel - Urine

213

1.55

1.62

1.2

—

(3017704) Immunofixation for Urine

113

1.77

1.60

1.7

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

2.50

1.59

1.0

175.00

167.50

g/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

159

1.64

1.58

1.8

1.5

4.60

5.59

u/l

0.16

135

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.70

1.58

1.0

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

248

1.50

1.54

3.4

2.5

1.63

1.48

g/24h

0.13

132

(3032773) Endomysium IgG Ab [Titer] in Serum

314

1.44

1.54

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

105

835

1.27

1.54

2.0

1.9

3.70

4.40

iu/l

0.56

313

(3023410) Appearance of Cerebral spinal fluid

340

1.42

1.52

2.6

2.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

115

1.74

1.52

1.2

1.1

81.83

311.69

ng/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

227

1954

1.17

1.51

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

2.16

1.50

2.1

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

714

1.28

1.50

1.3

238.52

250.34

u/ml

0.15

425

(3020891) Body temperature

113

913

1.25

1.46

3.7

4.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

117

1.71

1.44

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.13

1.44

1.2

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.97

1.43

2.0

2.9

1.70

2.12

mmol/l

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

197

1.53

1.40

1.4

70.50

75.76

umol/l

0.90

197

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.86

1.40

2.0

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

536

4910

1.11

1.39

4.7

4.4

2.33

2.40

ug/l

0.05

484

4397

(3039000) Anion gap in Blood

493

1.32

1.39

5.7

7.3

11.47

11.29

mmol/l

0.23

438

(3001556) Androgen free Index in Serum or Plasma

2.08

1.38

1.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.08

1.38

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.08

1.38

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

670

1.28

1.37

1.7

1.4

0.58

0.41

nmol/l

0.26

540

(3018572) Chloride [Moles/volume] in Blood

494

1.32

1.37

5.7

7.3

105.51

105.29

mmol/l

0.12

439

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

160

1.57

1.31

1.4

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

2.50

1.30

1.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

109

1326

0.82

1.30

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

2.10

1.30

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.36

1.29

1.8

1.9

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.29

1.26

1.1

20.19

38.00

mg/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

519

1.30

1.26

1.1

192.04

974.50

iu/ml

0.43

143

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

170

1.53

1.25

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.74

1.25

1.9

2.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

204

1.47

1.22

1.5

1.4

45575.41

85134.31

e6/l

0.40

121

(40758292) HTLV I+II Ab panel - Serum

1.97

1.22

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.63

1.21

7.8

6.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.63

1.21

7.8

5.8

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

271

1.41

1.21

1.8

2.2

31.97

32.17

0.13

271

(3043409) Potassium [Moles/volume] in Arterial blood

683

1.25

1.20

3.1

4.0

3.84

3.85

mmol/l

0.08

677

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

165

1417

1.17

1.19

1.4

1.3

192.94

229.21

miu/ml

0.78

713

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.11

1.18

2.3

1.7

—

(3025130) Human papilloma virus identified in Specimen

560

1.27

1.18

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

1.88

1.18

2.7

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

256

1.41

1.17

1.1

—

(3000330) Specific gravity of Urine by Test strip

151

1290

1.18

1.16

3.8

3.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.00

1.16

1.3

2.31

3.34

mmol/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

199

1739

1.15

3.4

3.0

41.13

46.54

u/ml

0.18

189

1674

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.05

1.15

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

110

1.64

1.15

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

266

1.40

1.14

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

126

1.59

1.14

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

150

1.54

1.14

3.5

3.9

6.90

7.88

mg/l

0.62

124

(3002079) Sodium [Moles/time] in 24 hour Urine

134

1.57

1.14

1.1

1.4

162.67

159.10

mmol/24h

0.06

134

(3014271) Vancomycin [Susceptibility]

103

1.65

1.12

2.9

2.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

405

1.31

1.12

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.90

1.12

1.5

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

235

1.41

1.08

1.3

1.5

11.22

11.20

umol/l

0.01

220

(21494755) Public health laboratory ask at order entry panel

332

3651

0.90

1.07

1.3

—

(4146454) Self-monitoring of blood glucose

236

1.40

1.06

2.6

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.79

1.04

1.4

2.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

1.04

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.79

1.04

1.4

2.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

246

1.39

1.03

1.4

35.61

33.21

g/l

0.44

222

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.06

1.02

1.3

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

114

1.58

1.02

1.2

—

(3024263) Appearance of Synovial fluid

122

1.56

1.02

1.4

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

230

1.39

1.01

2.3

1.5

1.31

promille

0.01

184

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

188

1.44

1.01

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

378

1.30

0.99

3.5

3.1

0.78

0.82

nmol/l

0.33

293

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1080

0.83

0.99

1.4

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

123

1.55

0.99

1.3

1.2

16.21

12.83

u/l

0.37

112

(3045462) Protein/Creatinine [Ratio] in Urine

1.81

0.98

4.7

6.4

41.92

69.22

g/mol

0.35

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.95

0.97

3.1

2.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

207

1.40

0.96

2.9

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

230

2061

1.12

0.95

4.5

3.4

1.23

mmol/l

0.54

201

1774

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

364

0.71

0.95

1.6

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.89

0.94

1.0

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.89

0.94

8.4

5.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

697

1.21

0.94

1.2

1.4

2.82

4.20

ug/l

2.08

641

(3017569) Oxygen content in Arterial blood

101

1.59

0.93

3.1

2.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

338

3097

1.10

0.93

7.1

6.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

436

1.27

0.92

2.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

218

0.64

0.88

1.4

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.79

0.87

5.4

6.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

111

1.53

0.87

1.0

1.3

—

(3035880) pH of Pleural fluid

103

1.56

0.87

1.1

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.00

0.87

5.3

3.0

—

(4034850) Laboratory test

106

907

1.17

0.86

8.8

8.7

—

(3003694) ABO and Rh group [Type] in Blood

970

9288

1.06

0.85

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

112

1.52

0.84

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.94

0.84

11.3

5.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

198

2204

0.89

0.84

1.3

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.55

0.81

1.2

1.1

—

(3012441) Differential panel - Pleural fluid

198

1.37

0.80

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.82

0.79

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.67

0.78

1.1

1.4

—

146.50

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

199

1.36

0.78

1.1

1.50

1.12

u/l

—

(3015183) Erythrocyte sedimentation rate

208

1.35

0.77

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.77

0.76

1.7

2.9

0.83

0.76

u/field

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

226

1.33

0.76

1.2

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

235

1.32

0.75

1.5

1.4

4263.05

2712.60

e6/l

0.38

167

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

309

2855

1.09

0.75

2.9

2.8

0.67

0.72

ug/l

0.29

186

1755

(40768806) Pleura Pathology biopsy report

201

1.35

0.74

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

125

1.44

0.72

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.80

0.72

2.0

1.9

—

(3002619) Bacteria identified in Specimen by Culture

1.67

0.72

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.75

0.71

2.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.58

0.71

1.1

1.2

—

(3003181) Sodium [Moles/volume] in Urine

435

1.22

0.70

1.5

1.4

72.65

65.05

mmol/l

0.58

356

(3047189) Immunofixation for 24 hour Urine

1.51

0.69

3.6

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

169

1.36

0.69

1.2

1.1

1308.13

1452.72

miu/ml

0.28

169

(3022670) pH of Venous cord blood

1.85

0.68

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

151

1355

1.12

0.67

1.7

1.6

4.95

4.07

mg/l

0.34

119

962

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.79

0.66

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

188

1.33

0.66

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

253

2739

0.92

0.66

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.54

0.65

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

251

1.28

0.64

1.5

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

1.73

0.64

1.2

—

(40761536) Microorganisms panel - Urine sediment

277

2573

1.08

0.62

5.0

3.6

—

(3036180) Methadone [Presence] in Urine

199

1.31

0.62

2.0

—

(3008037) Lactate [Moles/volume] in Venous blood

461

1.20

0.62

4.3

2.8

1.48

1.51

mmol/l

0.09

447

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

413

3897

1.07

0.61

4.2

3.9

20.24

21.11

0.55

168

1695

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

125

1392

0.89

0.59

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

132

1.37

0.57

1.1

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

429

1.19

0.56

4.2

2.9

7.72

7.42

mmol/l

0.28

418

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

671

1.15

0.56

2.0

1.9

—

(3020650) Glucose [Presence] in Urine

0.57

0.56

1.0

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.62

0.55

9.7

7.4

—

(3009871) Measles virus Ab [Titer] in Serum

107

1.40

0.55

1.6

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

145

1319

1.10

0.54

1.9

2.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

299

3181

0.93

0.53

1.6

—

(40768441) Liver Pathology biopsy report

205

1.27

0.52

1.1

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

250

1.24

0.52

1.5

2.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.61

0.51

10.3

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.61

0.51

5.2

2.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.45

0.51

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

288

1.22

0.50

1.2

30.60

38.39

mg/l

0.94

233

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

127

1.34

0.49

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.52

0.48

1.1

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

218

1.24

0.46

1.1

1.09

1.04

ratio

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.43

0.46

2.0

1.7

7.31

682057.70

nmol/l

—

(3051593) INR in Capillary blood by Coagulation assay

1.43

0.45

1.2

10.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

330

0.82

0.44

2.7

16.93

21.35

nmol/l

1.79

318

(3020491) Glucose [Moles/volume] in Blood

238

1.22

0.44

1.4

1.9

6.41

6.32

mmol/l

0.10

178

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

151

0.73

0.42

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

113

1.33

0.42

4.5

3.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.56

0.42

4.2

8.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.38

0.42

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

127

1380

0.92

0.41

1.6

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

184

0.76

0.41

3.1

6.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.52

0.41

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.52

0.41

6.6

3.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.52

0.41

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.52

0.41

4.0

6.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

217

0.78

0.41

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

277

1.19

0.41

1.2

1.1

184.76

245.58

mg/l

2.58

236

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

159

1.26

0.40

2.3

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.40

1.2

1.1

—

(3000012) Reticulocyte production index

279

1.18

0.38

1.7

2.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.39

0.38

1.2

1.1

1.46

1.89

mmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.39

0.38

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.34

0.38

1.2

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

107

1.31

0.37

1.4

2.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

660

1.11

0.35

1.1

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

144

1.25

0.35

1.2

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

227

1.19

0.34

1.7

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

671

1.10

0.34

1.2

—

(40765096) Chromosome analysis panel by Banding

1.34

0.34

1.4

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.33

0.33

1.2

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

264

0.83

0.33

1.1

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.68

0.33

1.8

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.33

0.32

1.1

—

(40768793) Breast Pathology biopsy report

695

1.10

0.31

1.3

—

(3005033) Fetal Nuchal fold Thickness US

123

1149

1.07

0.30

1.5

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.31

0.30

1.3

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.27

0.30

1.3

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

185

1.19

0.29

1.2

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

123

1153

1.07

0.28

1.5

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

126

1184

1.07

0.27

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.25

0.27

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

666

6506

1.03

0.27

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

104

1.25

0.26

1.4

47.62

87.28

nmol/24h

2.64

104

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

181

0.83

0.25

1.3

1.4

140.06

165.54

pmol/l

0.42

181

(3022689) Creatine [Moles/volume] in Urine

1.17

0.24

1.4

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.17

0.24

1.9

1.4

7.07

8.54

ug/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.74

0.24

2.8

2.2

10.17

16.68

umol/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

148

1408

1.05

0.23

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.32

0.23

1.2

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.28

0.23

11.0

3.7

50.34

42.02

umol/l

—

(3006598) pH of Arterial cord blood

1.24

0.23

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

216

2077

1.04

0.22

1.8

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.22

0.22

1.6

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

144

1.18

0.22

3.0

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

144

1.18

0.22

3.0

2.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

148

1412

1.05

0.21

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

12.6

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.45

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.0

—

431.83

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

101

0.79

0.21

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

239

1.13

0.21

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

1.45

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

148

1415

1.05

0.20

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

148

1416

1.05

0.20

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.18

0.19

2.0

1.3

—

(3042517) Benzodiazepines panel - Urine

1.13

0.18

1.2

2.2

—

(4281824) Cell count and differential, peritoneal fluid

301

0.90

0.18

1.1

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.21

0.18

2.4

2.2

—

(3044007) Cell count panel - Peritoneal fluid

0.75

0.17

1.4

2.1

—

(3006653) Thiamine [Moles/volume] in Blood

141

0.85

0.16

1.5

1.4

111.75

131.22

nmol/l

0.75

141

(3039443) Prostate specific Ag panel - Serum or Plasma

350

1.09

0.16

1.5

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.21

0.15

1.6

2.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

203

0.89

0.15

1.7

2.3

1.64

2.20

u/field

0.40

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.10

0.15

1.0

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.78

0.14

1.1

1.2

—

10.50

—

(40768446) Kidney Pathology biopsy report

112

1.16

0.14

1.9

1.7

—

(40768800) Prostate Pathology biopsy report

276

1.09

0.13

1.1

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

137

0.88

0.12

3.2

2.3

48.50

50.99

umol/l

0.10

118

(1617658) Protocol used for examination of sentinel lymph nodes

240

0.92

0.11

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

124

1.13

0.11

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

219

0.91

0.11

2.6

3.1

159.23

33.98

mg/l

0.38

163

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

157

1535

1.02

0.09

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.81

0.08

1.4

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

224

1.07

0.08

1.6

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

182

1792

1.02

0.06

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

315

1.05

0.06

2.0

4.5

69.08

76.71

u/ml

—

103

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

197

1.07

0.06

1.4

1.3

1.53

1.58

g/l

0.36

197

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

100

1.10

0.05

1.6

2.9

76.67

141.83

ng/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

580

0.98

0.02

5.3

4.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

183

1.04

0.01

1.3

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

583

1.01

0.01

3.5

3.4

27.78

24.23

mg/l

0.31

363

(3033705) Calcium.ionized [Moles/volume] in Venous blood

244

1.02

0.00

3.6

2.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

132

0.98

0.00

2.7

3.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

138

1.01

0.00

2.8

3.3

1.17

1.47

ug/l

0.29

129

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

548

1.00

0.00

2.3

2.4

167.14

123.01

ug/min

0.18

344

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

134

0.97

0.00

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

124

0.97

0.00

2.3

2.0

4.74

3.11

ug/l

0.26

113

(40765089) Chromosome analysis panel - Blood by G-banded

153

0.98

0.00

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.2

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

1.78

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.02

-0.00

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.91

-0.00

1.0

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

1.02

-0.00

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

3.00

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.85

-0.00

1.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.85

-0.00

9.6

6.4

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.02

-0.00

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.02

-0.00

1.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_URTICA_ALLERG and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_URTICA_ALLERG	1.201 [1.06, 1.36]	0.004
Birth year	0.998 [0.99, 1.01]	0.694

During the follow-up period (1.1.1998 — 31.12.2019), 1258 out of 15742 females with L12_URTICA_ALLERG died.

Males

Parameter	HR [95% CI]	p-value
L12_URTICA_ALLERG	1.402 [1.22, 1.61]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 791 out of 11004 males with L12_URTICA_ALLERG died.

Mortality risk

Mortality risk for people of age

years, who have L12_URTICA_ALLERG.

N-year risk	Females	Males
1	0.141%	0.233%
5	0.869%	1.554%
10	2.144%	4.065%
15	3.882%	7.337%
20	6.668%	12.586%

Relationships between endpoints

↥

Index endpoint: L12_URTICA_ALLERG – Allergic urticaria

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Allergic urticaria

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints